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ABSTRACT
Understanding the cellular membrane interaction with membrane active biomolecules and
antimicrobial agents provides an insight in their working mechanism. Here, we studied the effect
of antimicrobial agents; a recently developed peptidomimetics E107-3 and colistin as well as the
N-terminal helix H0, of Endophilin A1 on the lipid bilayer.
It is important to discern the interaction mechanism of antimicrobial peptides with lipid
membranes in battling multidrug resistant bacterial pathogens. We study the modification of
structural and mechanical properties with a recently reported peptidomimetic on lipid bilayer. The
compound referred to as E107-3 is synthesized based on the acylated reduced amide scaffold and
has been shown to exhibit good antimicrobial potency. This compound increases lipid bilayer
permeability as indicated by our vesicle leakage essay. Micropipette aspiration experiment shows
that exposure of GUV to the compound causes the protrusion length Lp to spontaneously increase
and then decrease, followed by GUV rupture. Solution atomic force microscopy (AFM) is used to
visualize lipid bilayer structural modulation within a nanoscopic regime. This compound induces
nanoscopic heterogeneous structures rather than pore like structures as produced by melittin.
Finally, we use AFM-based force spectroscopy to study the impact of the compound on lipid
bilayer’s mechanical properties. With the incremental addition of this compound, we found the
bilayer puncture force decreases moderately and a 39% decrease of the bilayer area compressibility
modulus KA. To explain our experimental data, we propose a membrane interaction model
encompassing disruption of lipid chain packing and extraction of lipid molecules. The later action

ix

mode is supported by our observation of a double-bilayer structure in the presence of fusogenic
calcium ions.
Polyanionic Lipopolysaccharides LPS are important in regulating the permeability of outer
membrane (OM) of gram-negative bacteria. To initiate the bactericidal activity of polymyxins, it
is essential to impair the LPS-enriched OM. Here, we study the mechanism of membrane
permeability caused by colistin (Polymyxin E) of LPS/phospholipid bilayers. Our vesicle leakage
experiment showed that colistin binding enhanced bilayer permeability; the maximum increase in
the bilayer permeability was positively correlated with the LPS fraction. Addition of magnesium
ions abolished the effect of LPS in enhancing bilayer permeabilization. Solution atomic force
microscopy (AFM) measurements on planar lipid bilayers shows the formation of nano- and macro
clusters which protruded from the bilayer by ~2nm. Moreover, increasing the fraction of LPS or
colistin enhances the formation of clusters but inhibits by magnesium ions addition. To explain
our experimental data, we proposed a lipid-clustering model where colistin binds to LPS to form
large-scale complexes segregated from zwitterionic phospholipids. The discontinuity (and
thickness mismatch) at the edge of LPS-colistin clusters will create a passage that allows solutes
to permeate through. The proposed model is consistent with all data obtained from our leakage
and AFM experiments. Our results of LPS-dependent membrane restructuring provided useful
insights into the mechanism that could be used by polymyxins in impairing the permeability barrier
of the OM of Gram-negative bacteria.
Also, we studied the effect of helix H0 of a membrane modification inducing protein
endophilin, on planar bilayer. We obtained transmembrane defects on the bilayer when
scanned.with AFM.
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1. INTRODUCTION
1.1

Cell membrane
Membrane bounds cells and cell organelles. This membrane, also known as the plasma

membrane, serves as a physical barrier to preserve the cytoplasm, protect from the toxic materials
and pathogens, mediate activities to pass between extracellular environment and cells, and separate
metabolic activities conducted within cells. Most of the cellular processes are directed by the
gradient of charges and concentration across the membrane. The membranes are composed of
lipids with embedded proteins, including peripheral, membrane, and transmembrane. The
thickness of the membrane is variable due to the presence of these proteins. However, the apical
plasma membrane purified from rat hepatocytes is found to be ~4.2nm [1] The membrane also acts
as a site for attachment of cell wall, glycocalyx, and the cytoskeleton. Lipids are arranged in the
bilayer with asymmetrical leaflets and comprise up to 50% by weight of the membrane. The
phospholipid is the most abundant lipid found in the biological mammalian membranes. The outer
leaflet of the mammalian plasma membrane mostly consists of choline phospholipids whereas
inner leaflet has predominantly amino phospholipids (PS and PE) [2]. The plasma membrane also
contains cholesterol in a significant amount which modulates the membrane fluidity. The
arrangement and composition of the membrane adjust constantly to maintain fluidity and effect of
the surrounding environmental changes. The model attributing the dynamic nature of a membrane
is best described by a fluid mosaic which was first formulated by Singer and Nicolson in 1972 [3].
This model is able to describe several cellular features related to the cell membrane. A sketch of
the cell membrane described by this model is shown in Figure 1.1
1

Figure 1.1 An updated Fluid—Mosaic Membrane Model that contains information on membrane
domain structures and membrane-associated cytoskeletal and extracellular structures.
Different integral proteins, glycoproteins, lipids and oligosaccharides are represented by
different colors, and where the membrane has been peeled-up to view the inner
membrane surface cytoskeletal fencing is apparent that restricts the lateral diffusion of
some but not all trans-membrane glycoproteins. Other lateral diffusion restriction
mechanisms are also represented, such as lipid domains, integral
membrane glycoprotein complex formation (seen in the membrane cut-away),
polysaccharide–glycoprotein associations (at the far top left) and direct or indirect
attachment of inner surface membrane domains to cytoskeletal elements (at lower left).
Although this figure suggests some possible integral membrane protein and lipid mobility
restraint mechanisms, it does not accurately present the sizes or structures of integral
membrane proteins, cytoskeletal structures polysaccharides, lipids, submicro- or nanosized domains or membrane-associated cytoskeletal structures or their crowding in the
membrane Image adapted form [4].

The design of the biological membrane to function in a complex environment where two
distinct aqueous compartments are separated by the intricate hydrophilic-hydrophobic interface is
the root problem to study them [5]. Thus, a simpler experimental model is used to study the
2

properties of the cell membrane. A membrane with single phospholipid or a mixture of few
component lipids is used for a lot of studies. Having Amphiphilic characteristic of lipid forces it
to self-aggregate in different structures. Depending upon the lipid structure, lipid-lipid interaction
and preparation environment, they form micellar aggregates, lamellar and non-lamellar liquid
crystalline phase of different topology [6, 7]. In fact, the self-assembly and organization of the
lipids are carried out by relatively weak forces comparative to thermal energy [8]. The enthalpy
component of the free energy arises from most central interactions like hydrogen bonding, Van
Der Waals bonding, and electrostatic interaction while the entropic component originates from the
thermal motion responsible for keeping lipid in fluid in motion[9].

Figure 1.2 Image of a typical phospholipid (POPC) which is found in the mammalian cell
membrane. Image adapted from[10]

In aqueous solution with amphiphilic molecules, the subtle competition between enthalpic
and the entropic forces represents the tendency to exclude the water molecules from a nonpolar
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molecule which leads to minimizing the free energy, F=E-TS. This leads to the self-aggregation
of the lipid molecules to sealed compartments in such a way that the contact of water molecules
restricts with the polar region of the lipids [9].

1.2

Bacterial membrane
The cell envelope of the bacteria is made of an inner plasma membrane and the rigid cell

wall. The plasma membrane is similar to the eukaryotic cell membrane mostly consisting of lipids
like phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin [11]. The presence of a cell
wall in a bacterial cell is essential to protect protoplast from the mechanical damages and withstand
large turgor pressure.

Figure 1.3 The bacterial cell wall. The Gram-positive envelope (a). The Gram-negative envelope
(b). In Gram-positive bacteria, the lipidic plasma membrane with embedded proteins is
covered by a multilayered peptidoglycan shell decorated with polysaccharides, teichoic
acids, and proteins. In Gram-negative bacteria, a thin peptidoglycan layer surrounds the
plasma membrane and is covered by an asymmetrical outer membrane containing
lipopolysaccharides, which lies on the peptidoglycan layer. Image adapted from [12]

The cell wall of gram positive-bacteria (g+) consists of the thick layer (around 15-80nm)
of peptidoglycan, also known as murine. Peptidoglycans are polymers of disaccharides (glycan)
4

which are linked by a short chain of amino acids (peptides). Teichoic acid, unique to the grampositive cells, runs perpendicular to the layers of peptidoglycan. Lipoteichoic acids, which are
anchored to the cell membrane, has its function related to growth, physiology, and development
of bacterial cell [13]. Wall teichoic acids are covalently bonded with a peptidoglycan layer which
is involved in cell division and maintaining the shape of the cell[14].
Gram-negative bacteria (g-) cell wall is composed of one or a few layers of peptidoglycan
encompassed by an outer membrane (OM). Peptidoglycan layer sits on the periplasmic fluid
between OM and the cell membrane. The OM is highly asymmetric; inner leaflet has lipid
composition similar to the inner membrane, and outer leaflet consists of lipopolysaccharides (LPS)
[11]. LPS are made of repeating unit of O-antigen, core region and Lipid A. LPS can hinder the
entrance of the drugs making the cell resistance towards them [15]

1.3

Model lipid membrane systems
The difficulty of achieving an exact replica of the cell membrane guides to preparing some

simple model membranes. Some of the experimental model membranes used for research purposes
are described below.
1.3.1 Black lipid membranes
This is one of the oldest model lipid-membrane systems, which was first described by
Mullers et.al. [16]. A thin aperture (order of few hundred micrometers) on hydrophobic support
like Teflon or polyethylene separates the two compartments with aqueous solutions. A mixture of
phospholipids in the relatively viscous hydrophobic solvent like hexane or decane is painted across
this small opening on the support. Monolayers of lipid are formed instantly at the interface of the
aqueous/organic solvent droplet. As the wall of the opening is hydrophobic, the solvent migrates
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towards it leaving the monolayer to fuse together with thinning at the center and leaving annulus
at the perimeter. A more uniform bilayer is prepared by pre-forming the lipid monolayer on one
side of the chamber in an aqueous solution and slowly lowering the solution level. This process
forms a single monolayer. The second monolayer of lipid is formed by pulling up the solution and
completes the bilayer [17] (Figure 1.4A) Electrodes can be placed at both sides of the bilayer
compartments to conduct the electrical measurement and patch clamping.

Figure 1.4 Images of model experimental lipid system. Black lipid membrane (BLM) (A) and
Langmuir monolayer (B)

1.3.2 Lipid monolayers
The half of a bilayer or monolayer is a monomolecular film formed at the air-water
interface and is obtained by spreading lipid molecules on the surface of an aqueous solution (Figure
1.4 B). The lipid solution dissolved in a highly volatile organic solvent is deposited on the water
surface in a trough. The organic solvent evaporates leaving the hydrophilic head group of lipid in
contact with an aqueous solution and hydrophobic hydrocarbon chain pointing in the air.
Monolayers are used to extract isotherm characteristics, which are obtained from surface pressure
6

as a function of area per molecule and are used to characterize the nature of phase separation. In
addition, so formed monolayers can be transferred to a smooth solid surface by Langmuir-Blodgett
(LB) or Langmuir-Schaefer techniques to obtain supported lipid bilayer. The former transfer
method uses vertical deposition whereas the latter uses the horizontal lifting of the monolayer.
This technique provides a very strong platform to study the intra-and intermolecular interaction at
interfaces [18]

Figure 1.5 Images of common lipid model membrane systems used for the experimental purpose.
Supported lipid bilayers (SLB)(A) and Liposomes (B).

1.3.3 Liposomes
Liposomes are the simplest model mimicking a closed, natural cell membrane of organisms
(Figure 1.5B). They are small artificial sphere shaped vesicles, which are developed from one or
more lipid components, mostly the non-toxic phospholipids. Liposomes are classified as
multilamellar vesicles (MLVs) consisting of several lamellae lipid bilayer and unilamellar vesicles
7

(ULVs) consisting of a single lipid bilayer lamella. Further, depending on the size, unilamellar
vesicles are classified as small unilamellar vesicles (SUVs, < 100 nm in diameter), large
unilamellar vesicles (LUVs, < 1000 nm in diameter), giant unilamellar vesicles (GUVs, > 1000
nm in diameter) [19]. Depending upon the lipid components used, the charge of the lipid
component, size, and methodology for the preparation, the properties of liposomes vary
considerably. Liposomes are used to study membrane interaction events, thermodynamic,
structural, and mechanical properties of the cell membrane. In recent years, the use of liposomes
is extensive as carriers for drugs and cosmetics due to its biocompatibility nature [20]. Entrapment
of hydrophilic and lipophilic drugs inside and within the lamella has made liposomes an excellent
vehicle for drug delivery [21].
1.3.4 Supported lipid bilayer
Supported lipid bilayers are the surface-confined model system with flat bilayers prepared
on top of the firm substrate like mica, silica, glass, etc. (Figure 1.5A). They can be prepared by
depositing lipid monolayers on a hard surface by langmuir deposition techniques, vesicle fusion
on the hydrophilic surface or self-assembled by rehydrating spin coated lipid surface[22] [19].
Solid-supported lipid bilayer formation by vesicle fusion includes two critical steps i) adhesion
and rupture of liposomes on the substrate forming patches and ii) formation of a complete bilayer
by subsequent evolution of bilayer patches[23]. One way of incorporating protein in the supported
bilayer is achieved by using a polymer cushion for the bilayer formation [24]. These models are
mostly used to study the interaction of drugs and proteins with membranes along with phase
behavior and molecular organization. There are several techniques and instruments to study a
variety of properties using model membranes.
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The following table includes some of the methodologies used depending upon the model
membrane.

Table 1-1 Main model membranes and techniques of study
Model membranes
Main techniques of study
Langmuir monolayers at air-water interface
Bidimensional stems with planar geometry
Ideally smooth, uncorrugated substrate
Temperature and surface controlles
Ion content and pH of the subphase controlled

Surface pressure-area isotherms
Brewster angle microscopy
Fluorescence microscopy
X-ray or neutron reflectivity, grazing incidence X-ray or
neutron scattering

Liposomes
Giant Unilamellar Vesicles(GUVs): geometry
and dimensions close to that of cells
Temperature controlled
Ion content and pH of the aqueous phase
controlled

Scattering techniques: quasi-elastic light scattering, small
angle X-ray (or neutron) scattering, wide-angle X-ray
scattering
Cryo-transmission electron microscopy, fluorescence
microscopy
Spectroscopic techniques: UV-visible, Fluorescence, Raman,
NMR Differential scanning calorimetry (DSC)

Supported monolayers or bilayers
Stability and well-defined geometry of the
membrane (planar of spherical for bilayers)
Asymmetric bilayers possible
Stacks of parallel bilayers possible

Atomic Force Microscopy (AFM), Fluorescence microscopy
X-ray or neutron reflectivity, grazing-incidence X-ray or
neutron scattering

Ion content and pH of the aqueous phase
controlled

Quartz crystal microbalance (QCM-D), surface plasmon
resonance (SPR),
UV-vis sum-frequency generation (SFG), second harmonic
generation(SHG)

Table adapted from [25]

1.4

Compounds used in the studies

1.4.1 Peptidomimetics E107-3
The increase of resistance towards drugs during the treatment of infectious diseases is an
alarming global threat to which thousands of people give lives yearly. Particularly the bacterial
pathogens, which have developed the antibiotic resistance, have grown up as superbugs. In
addition, the resistance of drugs for the treatment of malaria [26], human immunodeficiency
virus/acquired immune deficiency syndrome (HIV/AIDS), tuberculosis [27], and many cancers
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[28] are reported. This promotes the seeking of diseases’ treatment with alternative drugs and
methodologies. Antimicrobial peptides (AMPs) are one class of promising agents in the treatment
of drug-resistant bacteria and have a large spectrum of activity. However, these molecules have
limitation regarding prone to proteolysis, short half-lives, etc. A slight modification in the structure
of these AMPs produces more stable and potent antimicrobial compounds, which are known as
peptidomimetics.

Figure 1.6 A design of peptidomimetics containing reduced amide (A). The blue colored side group
R1 is positively charged; the red colored side groups R2, R3, and R4 are hydrophobic. (B)
The chemical composition of the antimicrobial E107-3 based on the scaffold shown in (A).
R2 contains a phenyl ring, and R3 and R4 each contains an adamantyl group. At neutral
pH, the two amines at R1 position are likely positively charged.

A group of such peptidomimetics is reduced amide derivatives, which has an amide bond
reduced on the backbone of α- peptide. This reduction of the amide bond to produce secondary
amine bond has significantly increased the stability against proteolytic degradation activity. One
such library of compounds is synthesized in Dr. Jianfeng Cai’s group in the Department of
Chemistry, USF. These compounds have four side chain of which R1 exhibits hydrophilic nature,
10

and the rest side chains are hydrophobic. One lead compound referred to E107-3 with a molecular
weight of ~660 is used for observing the changes imparted on the membrane bilayer. The two
amines at R1 position of E107-3 are likely to exhibit positively charge at neutral pH.
1.4.2 Colistin

Figure 1.7 Chemical structure of colistin. The amphipathic peptide is composed of a heptapeptide
macrocycle, an exocyclic tripeptide, and an acyl tail. Colistin has two hydrophobic
domains, including the acyl chain and the hydrophobic patch of the macrocycle at positions
6 and 7. Cationic diaminobutyric acids are located at positions 1, 3, 5, 8, and 9.

Colistin is a cyclic lipopeptide belonging to polymyxin family, which possesses
antimicrobial activity against gram-negative microbes. It consists of the heptapeptide ring of
polymyxins enriched with cationic diaminobutyric acid (DAB). The C-terminus of the exocyclic
tripeptide is fused to the macrocyclic ring, while the N-terminus is linked to a fatty acid tail
(prominently 6-methyl-octanoic acid). Colistin was first isolated from the Gram-positive
bacterium Bacillus colistinus and was used for clinical application since the 1950s. Due to
observed nephrotoxicity and neurotoxicity accompanied by colistin administration on patients, its
practice was gradually receded. However, due to the development of Multi-drug resistance species,
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it has generated a new interest due to its antimicrobial activity and low susceptibility against
bacteria [29].
1.4.3 N-BAR Endophilin amphiphilic helix H0
Endophilin is a BAR (Bin/Amphiphysin/Rvs) protein associated with sensing and inducing
membrane curvature during the process of endocytosis. It consists of a banana-shaped dimeric
structure with identical three helixes coupled together. The N-BAR endophilin consists of
additional helix H0 at the N-terminal. For the dissertation work, we used N-terminal helix H0 of
human endophilin A1 which consists of 24 amino acids.

Figure 1.8 Human endophilin-A1 BAR domain.Image adapted from PDB with id:1ZWW and
reference [30]

The amino acid sequence of this helix 0 is MSVAGLKKQFHKATQKVSEKVGGA. This
helix H0 rearranges to form an amphiphilic helix coil when it comes in contact with membrane
and inserts into the membrane. However, controversial results have been published earlier
regarding the role of this helix in sensing and inducing membrane curvature.

12

1.5

Motivation for studies
This dissertation aims for the model membrane interaction studies with a member of

peptide mimics E107-3, antimicrobial lipopeptide colistin and a membrane curvature-inducing
fragment of Endophilin BAR domain.
The preliminary study of the bacteria treated with E107-3 indicated that it induces
permeability of propidium iodide to the membrane, a signature of compromising bacterial
membrane.[29]. This indicates the possibility of this compound to be a potential antimicrobial
agent that acts by targeting and damaging bacterial membranes. Membrane damage induced by
AMPs can proceed with different mechanisms, such as pore formation and detergent-like
membrane disintegration [31]. During the process of membrane disruption, structural change and
modulation in mechanical properties can occur. This work is motivated to elucidate the mechanical
and surface changes that occur on the model lipid membrane induced by the peptidomimetics
E107-3.
Polymyxins have grown a renewed interest in the treatment of multidrug-resistant species.
The activity of polymyxin is believed to be related to the impairment of LPS on the outer
membrane (OM) of bacterial cells. To study the interaction of the OM of bacterial cells with
polymyxin several LPS containing vesicular system or monolayers has been employed but only
limited studies on the planer model. Previous two AFM studies on planar bilayer with Polymyxin
were based on Lipid A and on a cushioned monolayer of biotinylated LPS. This limited work on
AFM based planar bilayer containing LPS with polymyxin motivated for this study. This study is
inspired to detail the nano-scale morphological changes impaired by colistin (Polymyxin E), and
the role of divalent cations on its effectiveness with LPS containing planner bilayer using AFM.
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Endophilin BAR domain protein is related to curvature sensing and generation as well as
recruiting other proteins for the endocytosis in cells. An amphiphilic N-terminal helix H0 is
believed to anchor the membrane and help to generate membrane curvature. Earlier research based
mostly on the curvilinear membrane or computational work has resulted in controversial outcomes
regarding curvature formation by helix H0. Planar membranes are sometimes an excellent model
for the peptide’s interaction studies. No such studies on planar membrane based upon AFM with
helix H0 have been conducted earlier. This study is motivated to decipher the modulation on
surface topography induced by helix H0 on planar bilayer made of different lipid composition.

1.6

Dissertation overview
This dissertation work focuses on the study of the molecular interaction of biomolecules

with the model lipid membranes.
Chapter 2 describes the materials and methods implemented for the whole study. This
includes the drugs and peptides, lipids and instruments used for the studies.
Chapter 3 deals with the study of a reduced amide scaffold based antimicrobial
peptidomimetics E107-3 with the model bilayer. Permeability of ULVs and the kinetic response
of GUVs with exposure of E107-3 is described in this chapter. Surface modulation of the supported
bilayer in the presence of the peptide mimics is imaged by using a solution AFM. A comparison
with a well-known pore-forming antimicrobial peptide melittin is also performed.
Chapter 4 details the interaction study of colistin with a lipid bilayer containing
lipopolysaccharides (LPS). It deals with the change in membrane structure introduced in a bilayer
with different LPS content due to the effect of colistin. A detail permeability behavior is studied
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using leakage experiment as well as atomic force microscopy (AFM). The effect of a divalent
cation on the permeability of LPS containing bilayer is also a part of the study.
Chapter 5 deals with the study of a membrane curvature promoting amphipathic helix H0
of the endophilin BAR domain on the supported bilayer. Transmembrane defects promoted by the
N-terminal helix H0 are visualized by AFM in topographic images.
Chapter 6 deals with the conclusion and future work.
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2. EXPERIMENTAL SETUP
2.1

Introduction
Lipid bilayers along with liposomes of different sizes and supported lipid bilayer (SLB)

were used for the experimental purpose. We used giant unilamellar vesicles (GUVs) for
micropipette aspiration experiment and unilamellar vesicles (ULVs) of smaller size for the
permeability experiment. For the preparation of supported lipid bilayers, we used small unilamellar
vesicles (SUVs). We also used a gram-negative species of bacteria, E.coli for the experiment.
In this chapter, we describe the experimental procedure for the preparation of the samples
and the methodology for the experimental purpose. In addition, we discuss some of the theoretical
backgrounds for those approaches.

2.2

Experimental approach

2.2.1 Permeability experiment
A commonly used experimental approach to investigate the leakage through the model
lipid membrane is permeability experiment. Permeability experiment is conducted by measuring
the amount of fluorescence markers that leaked from the dye encapsulated unilamellar vesicle due
to the addition of the compound of interest. Commonly used markers for such experiments are
self-quenching dyes like carboxyfluorescein and calcein. Generally, unilamellar vesicles, which
are encapsulated with the markers, are incubated with the compounds of interest. These
compounds might compromise the membrane and induce leakage of the marker from the
enclosure. This release process can occur in two ways: i) graded process in which the vesicles
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release portions of their loadings or ii) all-or-none in which some fractions of the vesicles release
all of their loadings or none at all [32]. The emission intensity due to the dequenching of
fluorescence dye after releasing from vesicles measures the leakage. Other approaches to
measuring the leakage include chromatographic separation [33], fluorescence correlation
spectroscopy [34], etc.
2.2.1.1 Unilamellar vesicles preparation and calcein encapsulation
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was purchased from either
Avanti Polar Lipids (Alabaster, AL) or NOF America. 1-palmitoyl-2-oleoyl-sn-glycero-3phosphoglycerol (POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), and
cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL). Stock solutions for these
lipids were prepared with chloroform or chloroform: methanol mixture (3:1 ratio). Melittin
purified from bee venom was purchased from Thermos Fisher Scientific (Waltham, MA). E107-3
was synthesized using solid phase synthesis method [29] by Dr. Jianfeng Cai’s group at the
department of chemistry, USF, FL. Calcein disodium salt and lyophilized LPS powder were
purchased from Sigma-Aldrich. LPS was phenol extracted from Pseudomonas aeruginosa whose
source strain is ATCC 27316. A stock solution of LPS was prepared in ultrapure water.
Dry lipid films were prepared in glass test tubes by mixing appropriate ratios of lipid stock
solutions. Around 1- 4mg of total lipid content was used for vesicle preparation. Organic solvents
were removed by a gentle stream of nitrogen gas using a 12-position N-EVAP evaporator
(Organomation Associates, Inc., Berlin, MA). The samples were further dried by vacuum pumping
for ~1 hour. The obtained lipid films were hydrated in 1ml 30 mM calcein and 10 mM 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) at pH 7.4 (now onwards known as buffer
A).
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Figure 2.1 Structure of POPC, POPG, POPE, and cholesterol. Images are adapted from [10] and
Avanti polar lipids

For LPS-containing samples, an appropriate amount of an LPS stock solution (in water)
was mixed with lipid suspension during the hydration process (total volume 1ml). We prepared
unilamellar vesicles by two methods:
i)

Freeze-thaw cycles between -80℃ and 50℃ were carried out to ensure uniform
distribution of calcein across the multilamellar vesicles (MLVs). The resultant lipid
solution was extruded using an Avanti mini-extruder outfitted with a 100 nm diameter
pore filter to produce ULVs.

ii)

Qsonica cup-horn powered by a Fisher brand model 705 sonic Dismembrator was used
to prepare calcein-enclosed unilamellar vesicles (ULVs) with LPS. The output power
of the sonicator was set at 50% and the total sonication time was 20 min (1-min on and
30-sec off)
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Figure 2.2 Chemical structure of lipopolysaccharide (LPS) from pseudomonas aeruginosa. Figure
adapted from [35]. Lipid A, core region, and repeat unit of O- Antigen region are
distinguished in figure.

External calcein was removed by using an ÄKTA Pure FPLC (GE Healthcare) and a gel
filtration column (Superdex 200,10/300GL). The elution buffer contained 45 mM NaCl and 10
mM HEPES (pH 7.4) (now onwards known as buffer B). The vesicles’ portions were fractionated
by monitoring UV absorption at 280 nm.
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2.2.1.2 Removal of calcein via SEC column on ÄKTA FPLC
Size exclusion chromatography (SEC) is a chromatographic technique used to separate the
solute from a solution depending upon its size or often molecular weight. Based on the elution
buffer used to transport sample on the column, it is referred to as gel filtration when the aqueous
buffer is used and gel permeation when an organic solvent is used.

Figure 2.3 ÄKTA Pure FPLC system from General electronics. The gel column is shown in the
figure above fractionates the solutes based on the size or the molecular weight of the
sample which is collected in rotatory fraction collection.

Since we prepared calcein encapsulated unilamellar vesicles in an aqueous medium, we
used gel filtration column to separate the ULVs from non-entrapped calcein solution. This
Superdex 200,10/300GL gel column has an exclusion limit for globular proteins (Mr) of
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approximately 1.3 x 106. The composites of cross-linked agarose and dextran with an average
particle size of 13 μm are packed in this column to form the bed. These composites consist of
spherical porous particles, which have none or minimal chemical and physical interaction. Initially,
the bed is filled with elute buffer, which covers the pores of matrix and spaces between the
particles. The stationary phase liquid inside the matrix is in equilibrium with the mobile phase
liquid outside of the particles. When the solution passes through the column, the molecules with
small size diffuse into the pores of spherical beads, which retard the flow of these particles. The
size of the solute entering the matrix determines the depth of diffusion within the matrix. These
molecules travel slower depending upon the degree of diffusion in the matrix. Large molecules are
excluded from the porous matrix and make an uninterrupted flow, which is faster than the small
molecules diffused in the matrix.

Figure 2.4 Schematics for preparing and separating dye encapsulated unilamellar vesicles
(ULVs). Calcein dye molecules are encapsulated in the ULVs used for dye leakage
experiments.
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In our experiment, the size of the calcein encapsulated ULVs are much larger than the
calcein molecules. Thus, calcein molecules are entrapped inside the gel due to diffusion whereas
the ULVs elute faster through the column, which is collected earlier during fractionation.
2.2.1.3 Fluorescence reading Experiment
To monitor the leakage of the calcein, FP-8300 spectrofluorometer (Jasco Analytical
Instruments, Easton, MD) was used. This device has continuous output Xe arc lamp with shielded
lamp housing having excitation and emission wavelength range of 200-750 nm. Solution samples
are filled in a quartz cuvette and placed in Peltier thermal cell holder (Model EHC-813).
2.2.1.3.1Working of Spectrofluorometer
Spectrofluorometery, which is also known as fluorescence spectroscopy or fluorometry, is
a type of analytical technique that can measure, record, and analyze fluorescence from the sample.
It is able to record both excitation and emission spectra. The main components of
spectrofluorometer consist of a light source, excitation monochromatic filter, sample holder,
emission monochromatic filter and a detector.
The Xenon lamp light source in our spectrofluorometer emits light from 200nm-750nm.
Before reaching the sample, the light passes through the excitation monochromatic filter that
blocks the entire source wavelength except the specified excitation wavelength. This
monochromatic light passes through the sample placed on the holder (cell cuvette) and is absorbed
by the fluorophore.
The absorption of the appropriate wavelength (λA) light excites the electrons of the
fluorophore from the ground state to the excited state with higher energy and vibrational energy
state within the order of femtosecond (10-15 sec). The excited electrons will rapidly (10-12sec) lose
its energy by internal conversion like vibrational relax to the lowest energy singlet excited state.
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This lowest energy singlet excited state electrons are able to relax back to the ground state by
emitting a photon of higher wavelength (λF). This shift towards larger wavelength for emission
light is called stokes shift. This emission continuous as long as the excitation sources and
fluorophores are present.
The emitted light is passed through the emission monochromatic filter preferably selected
at the wavelength of highest emission intensity for particular fluorophore. This filter is positioned
at a right angle to the path from the incident excitation source. This geometry reduces the possible
interference of emission light with transmitted excitation light. The light passing through this filter
reaches the detector, which measures and quantifies the fluorescence value of emitted light and
also fluorescence signature of a fluorophore.

Figure 2.5 FP-8300 spectrofluorometer (A) and schematics for the pathway of the
spectrofluorometer (B). The light emitted from the source passes through monochromatic
filter, which excites the fluorophore, and the light emitted ray from the fluorophore passing
through emission monochromatic filter is collected in detector
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We studied the vesicle leakage by two methods:
i)

Time course
For kinetic calcein leakage study (23°C), an aliquot of E107-3 or melittin stock solution

(in buffer B) was diluted with buffer B to make a final volume of 1990 μL. The solution was
transferred to a 3-mL quartz cuvette placed in a Peltier thermal cell holder of the
spectrofluorometer. A small magnetic rod was used to stir the solution (300 rpm). Right before
each measurement, 10 μL of calcein-enclosed POPC/POPG(9:1) ULVs prepared by method (i)
was pipetted into the cuvette. Time-course fluorescence intensity was collected every 0.5 or 1.0
sec for fast kinetics, and 1.0 min for slow kinetics. To alleviate photobleaching, the excitation gate
was closed between data points for 1.0-min-interval measurements. The obtained fluorescence
intensity was calibrated by the maximum intensity (Imax) when complete leakage occurs. Imax is
determined by adding 200 μL of 200 mM Triton X-100 (in buffer B) to 10 μL ULV stock and 1790
μL buffer B.
ii)

Steady-state fluorescence
Steady-state fluorescence spectroscopy measurements were performed for 10 μL

POPC/POPG(9:1) ULV stock solutions incubated with different concentrations of E107-3 and
melittin with the volume of 1990 μl for about ~20 hours. Maximum fluorescence intensity of the
sample was determined by adding 200 μl of 200 mM Triton X-100 (in buffer B) to 10 μl ULV
stock and 1790 μL buffer B.
Similarly, for the vesicles containing different amount of LPS, 30 μl of calcein
encapsulated ULVs were added to the 970 μl colistin solution of different concentration prepared
in buffer B. To obtain maximum vesicle leakage, the colistin solution was substituted with the
nonionic surfactant Triton X-100 (final concentration of 20 mM). The vesicle-colistin mixtures
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were incubated in the dark for 20 h. These samples were transferred to a quartz cuvette and placed
in the cell holder to measure the emission spectrum.
For both of the methods, the excitation wavelength used was 494 ± 2.5 nm. The emission
spectrum was measured from 500 to 600 nm (bandwidth of 2.5 nm). Three measurements were
performed for each sample. The maximum intensity at 515 nm of the emission spectrum was used
for vesicle leakage evaluation. Fluorescence enhancement (FE) or Vesicle leakage % was
calculated using the following equation:

𝐿𝑒𝑎𝑘𝑎𝑔𝑒 % = (𝐼 − 𝐼0 )/ (𝐼𝑚𝑎𝑥 − 𝐼0 ) × 100%,
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑐𝑒𝑛𝑐𝑒 𝐸𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡(𝐹𝐸) =

𝐼(𝑡) − 𝐼0
× 100%
(𝐼𝑚𝑎𝑥 − 𝐼0 )

(2.1)
(2.2)

Where I0 is the fluorescence intensity of control vesicles, Imax is the fluorescence intensity
of vesicles treated with Triton X-100, and I is the fluorescence intensity of vesicles treated with
different concentrations of agents and I(t) is the fluorescence intensity at each time step for time
course experiment.
2.2.2 GUV experiment
The other method that we used for our experiments is using giant unilamellar vesicles
(GUV). We prepared GUVs and used them for micropipette aspiration experiments to obtain the
change in membrane property as an effect of E107-3.
2.2.2.1 GUV preparation
GUVs were produced by the electroformation method [36]. A mixture of 0.2 mg
POPC/POPG (10:1) and 1.0 mol% Rh-DPPE (total volume of 200 µL in chloroform/methanol 3:1)
was deposited onto two ITO coated glass slides. Organic solvents were removed by vacuum
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pumping for >1 h (2-stage, 5 CFM). A Viton O-ring was placed between the two slides to form a
GUV production chamber, which was filled by 500 μL 100 mM sucrose.

Figure 2.6 Structure of calcein disodium salt (A). Image is adapted from [37]. The emission
spectrum of calcein molecules leaked from POPC vesicles obtained by treating with
surfactant. The emission intensity peaks at 515 nm (B)

The two slides were clamped together, inserted into a homemade aluminum block, and
heated to 60oC using a Digi-Sense temperature controller (Cole-Parmer). An AC field of 10 Hz
and 2.0 Vpp was applied to the heated assemblage for 2 h. After the AC field was turned off, the
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assemblage was gradually cooled to room temperature (-5oC per hour controlled by the
temperature controller). GUV solution was harvested and mixed with 3 mL of 100 mM glucose
solution. After settling for ~30 min, GUV aliquot pipetted from the bottom was diluted with 100
mM glucose and used for aspiration experiment.
2.2.2.2 Micropipette aspiration (MA) experiment
We performed micropipette aspiration (MA) experiments to extract the mechanical
properties of the GUV in presence of the peptidomimetics. This method provides the qualitative
response of single vesicle, unlike permeability experiment that provides the global averaged
response on the vesicles. This MA method was pioneered by Evans and Rawicz group, which
employs an external mechanical force to probe vesicles deformity in the form of the aspiration
length of GUV inside the micropipette. Such superficial pressure on the pipette(P), produces a
uniform membrane tension (𝜏𝑚 ) on the vesicle, depending on the micropipette diameter and the
diameter of the spherical section of the vesicles given by:

𝜏𝑚 = 𝑅𝑝 𝑃/2(1 −

2𝑅𝑝
)
2𝑅𝑣

(2.3)

Where 2𝑅𝑝 and 2𝑅𝑣 are the diameter of the micropipette and the spherical portion outside
of micropipette respectively. In addition, the length protrusion inside the micropipette is altered
by either a change of temperature or pipette pressure or the effect of external agents. Whatsoever,
the change in protrusion length (Lp) is related to the change in area and volume which is given by:

∆𝐴 ≈ 𝜋 [2𝑅𝑝 . 𝐿𝑝 . (1 −

2∆𝑉
𝑅𝑝
⁄𝑅 ) +
]
𝑣
𝜋𝑅𝑣
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(2.4)

However, the volume of the vesicles remains effectively constant for the area experiment,
which approximates the second part of the above equation to zero [38, 39].

Figure 2.7 Structure of melittin. PDB id is 2MLT

2.2.2.3 Micropipette aspiration set up
A micropipette was manufactured by pulling and polishing. Briefly, a 1-mm glass capillary
was pulled by a Narishige PN-30 magnetic glass microelectrode horizontal puller (East Meadow,
NY). The sharp end of the pulled capillary was cut and polished by a Narishige MF-900
microforge. For GUV aspiration, the capillary was typically cut at a position, so the resulting
micropipette has an inner diameter of 10–20 μm. The forged micropipette was inserted into a
Narishige HI-7 injector holder, which was mounted to a motorized MP-225 micromanipulator
(Sutter Instrument, Novato, CA). To control the pressure at the micropipette tip, we connected the
injector holder to a silicone tubing filled with 100 mM glucose. The open end of the tubing was
fixed to a motorized vertical translator (Velmex Inc., Bloomfield, NY).
The pressure at the micropipette tip was tuned by adjusting the height of the open end of
the tubing. Our GUV aspiration experiment (23oC) followed the procedure reported by other
groups [40-43]. Two wells were made by placing silicone sheets (Grace BioLabs, Inc.) on a glass
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coverslip. The first well contained a diluted GUV solution (~300 μL), and the second well
contained the desired peptide concentration in 100 mM glucose (~200 μL).

Figure 2.8 Micropipette aspiration setup. The glass coverslip with attached silicon wafer wells is
on top of Nikon inverted microscope (A). Blue arrow shows the tube filled with buffer liquid
(glucose 200mM) for pressure adjustment and orange arrow points the micropipette
holder. The transferring of single GUV to the peptide solution. (B). The steps include;
micropipette is brought closer to GUV solution (i) single GUV is attached to the
micropipette by applying negative pressure (ii), GUV containing micropipette covered with
a transfer pipette and escort to peptide solution (iii), and removal of transfer pipette to
expose aspirated GUV to the peptide solution (iv).

The coverslip was mounted on an inverted Nikon Eclipse Ti-U fluorescence microscope
(Nikon Instruments Inc., Melville, NY). The forged micropipette was inserted into the GUV well
by using the motorized micromanipulator. A selected GUV was aspirated when there was a small
constant negative pressure at the micropipette tip compared to the well solution. (The magnitude
of the negative pressure was adjusted by moving the vertical translator.) To obtain the real-time
effect of E107-3 on GUV area/volume properties, the micropipette with an aspirated GUV was
inserted into a transfer-pipette (I.D. of 0.75 mm) filled with 100 mM glucose. The transfer-pipette
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and the micropipette were simultaneously moved to the reaction well containing 5 μM E107-3 in
100 mM glucose. The transfer-pipette was retracted from the micropipette using a manual
micromanipulator (MM33, World Precision Instruments). The real-time response of the aspirated
GUV to E107-3 was monitored by fluorescence video images acquired using a CFI Super Fluor
ELWD 60× Ph2 objective and an Andor EM-CCD camera (iXon Ultra 897). The exposure time
for each video image was 50 ms, and the video frame rate was 2 Hz. To diminish the effect of
water evaporation on osmolality imbalance, both the GUV well and the reaction well were
refreshed every ~10 min.
2.2.3 Atomic Force Microscopy (AFM) experiment
AFM is a scanning probe microscopy (SPM) which has the capability of detecting forces
in single molecule level. Due to the possibility of operating in any environment, AFM has gained
extensive attention in a wide area of research, including material characterizing [44, 45],
biomedical[46], engineering. AFM has been an important tool for studying biological samples as
it can provide close to physiological settings.
A general working diagram of an AFM is shown in Figure 2.9. It consists of a cantilever
with an attached sharp tip, three-dimensional piezo scanner, laser system with a position sensitive
photodetector (PSPD) and a controller for a feedback loop. The sample placed on the piezo scanner
is brought in close proximity to the tip which develops the van der Waals force. As the tip
approaches the surface, the long-range van der Waals force attracts the cantilever to the sample.
However, when the tip is brought in contact with the sample, the short-range repulsive van der
Waals force deflects the cantilever in the opposite direction. This motion in cantilever is recorded
by the deflection of the laser beam reflected from the tip of the cantilever to a PSPD which is used
to reconstruct topographical images as well as discern several other mechanical information. A
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fluid-compatible Multimode 8 AFM (Bruker, Santa Barbara, CA) and a Nanoscope V controller
were used for the studies. The components of the AFM is shown in Figure 2.10(A).

Figure 2.9 Schematics of the working of AFM. The laser beam is incident on the tip of the
cantilever probe which might deflect while scanning. The position sensitive detector is very
sensitive to detect the slight change in direction of a reflected laser beam off the cantilever.
The controller processes the signals for display and provides appropriate feedback in the
system.

2.2.3.1 Components of Multimode AFM Bruker
The main components of the AFM are similar for most AFM systems although they are
placed in a different region of the system during set up. Here, we describe the main components
of the multimode AFM from Bruker.
i)

SPM system
SPM system in multimode AFM consists of the scanner, scanner support ring, and base.

There are several scanners based on the need of scanning parameters like longer type ‘J’ scanners
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and shorter type ‘A’ scanner. The longer type scanner provides a larger field of scan whereas
shorter scanner scans smaller images but with higher resolution.

Figure 2.10 Image of multimode AFM from Bruker. The different components of AFM; setup,
controller, head ,and holder are shown in (A).. The encircled region in holder is the
position for holding the AFM probe. The enlarged view of the AFM probe(B). Adapted
from [47]
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These scanners consist of piezo crystal, which translates the stage or the probe as a response
to the voltage supply. In our experiment, we used a longer type ‘J’ scanner to collect signals.
It also consists of a scanner support ring to attach the scanner and a base that has an LCD
to display the detector parameters
ii)

Controller
Controller of an AFM is to process the captured signal and provide the necessary feedback

for the scanning purpose. The feedback system of the AFM is generated as a response to a deviation
of signals from the constant set points like deviation/force or amplitude. In our system, we used
the nanoscope V controller.
iii)

Head
The head in multimode AFM consists of the laser source, probe holder attachment system,

position sensitive photodetector (PSPD), and an attached XY-stage. The laser beam is incident to
the cantilever probe in the probe holder which reflects and reaches the photodetector via tilt mirror.
This photodetector consists of four elements. The differences of the signal between the sum of the
top two elements (A) and the bottom two elements (B) is displayed as a vertical signal in a display
of base. Similarly, the signal difference between the sum of left two (C) and the right two (D) is
displayed as a horizontal signal [48]. Whereas, the total sum of the signals of all the four elements
is displayed as ‘SUM’, which should be maximized during the setup.
iv)

Probe holder and probes
The probe holder attaches the probe in position while scanning and taking measurements

in AFM. Depending upon the mode of scan and sample type, the probe holder might be different.
We used special fluid cell made of glass for most of the scanning as we scanned our samples in an

33

aqueous medium. In addition, a standard probe holder was employed for some measurement to
perform in the air.
AFM probes consists of a sharp tip placed at the end of the cantilever, attached to the chip
(Figure 2.10B). The radius of the tip ranges from a few nanometer to few tens of nanometer.
Usually a beam cantilever or a V-shaped cantilever is attached to the chip whose deflection is
recorded during AFM measurement.
2.2.3.2 Primary modes of Imaging
i)

Static or Contact mode
In this mode, the tip of the cantilever is in continuous physical contact with the sample at

all the times while scanning either by keeping the force constant or the height above the sample
constant. Cantilever deflection provides the feedback for this mode while operating in constant
force while no force feedback is provided while operating in constant height mode. This mode can
be useful for imaging the samples in the air which can handle high loads. Tip contamination,
sample damage, tip damage, distorted images are some of the drawbacks of contact mode.
ii)

Non-contact mode
In non-contact mode, the tip of AFM probe hovers 5-15 nm above the sample. Since the

interacting forces are very weak to detect, the cantilever is provided with a small oscillation so that
the change in frequency, amplitude or phase in oscillating cantilever due to force gradient with the
sample occurs. These changes in cantilever are used to detect the sample properties. Lowresolution images and contamination on the sample surface limit the usage of non-contact mode.
iii)

Tapping mode
This advanced hybrid mode of contact and non-contact mode scans the sample by

alternatively placing the probe in contact with the sample and withdrawing off to prevent dragging.
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The cantilever is oscillated at or near the resonant frequency during scanning with a constant
amplitude provided by a feedback loop. When the oscillating cantilever approaches the sample, it
loses its oscillation due to energy loss as it contacts the surface. This change in oscillation
amplitude is used to map surface features and measure the surface property. Cantilevers used in
fluid for tapping mode are generally soft < 1 N/m, whereas more rigid cantilevers are used to
operate in air mode (1-100 N/m).
2.2.3.3 PeakForce Quantitative Nanomechanics (PF-QNM)
We used peakforce quantitative nanomechanics (PF-QNM) mode for all our experimental
purpose. This mode accesses the high-resolution mechanical mapping of several sample properties
with very little or no destruction of the sample or the tip. In peak force tapping mode, the probe
and sample are brought together intermittently at a periodically modulated frequency by
controlling the maximum force, called peak force, using a system feedback loop. This modulation
frequency is well below the cantilever resonance frequency. At each period, the interaction force
is measured directly by the deflection of the cantilever. This interaction force is converted to forceseparation plots, which enable to determine several QNM information such as elastic modulus, tipsample adhesion, energy dissipation, and maximum deformation. Such sample properties are
extracted by fitting different regions of the calibrated force curve with corresponding models. For
example, the reduced Young's modulus E* is obtained from the retract curve region as shown in
Figure 2.11(iv) using the Derjaguin, Muller, Toropov (DMT) model given by

𝐹𝑡𝑖𝑝 =

4 ∗
𝐸 √𝑅𝑑 3 + 𝐹𝑎𝑑ℎ
3
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(2.5)

Where 𝐹𝑡𝑖𝑝 is the force on the tip, 𝐹𝑎𝑑ℎ is the adhesion force, R is the tip end radius and d
is the tip sample separation.
However, obtaining this information is limited to a single point of interaction in peak force
tapping mode. PF-QNM system enables to acquire such information for each pixels of collected
data and display to the corresponding image channels scanning across the sample [45, 46].
Although the maximum deflection of the cantilevers is held constant, the raised and the lowered
feature of the sample surface influences the deflection and piezo position of the cantilever. By
using a feedback loop to control the tip-height above the surface, and monitoring tip deflection for
corresponding influences, topographic images of the samples are reconstructed.
This mode of operation does not require resonating the cantilever, eliminating the necessity
of cantilever tuning, so it is particularly advantageous in scanning samples in solution.

Figure 2.11 Peakforce QNM mode scanning process The force curve captured at each pixcels are
simultaneously converted to the mechanical properties based on the different regions of
curves as shown in figure (iv). The images based on the properties are displayed in multichannel display. Image courtesy of Bruker Nano Surfaces [48].
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2.2.3.4 Bilayer sample preparation
The lipid mixtures were prepared by mixing the appropriate ratio of stock solutions in glass
test tubes. Organic solvents were removed by a gentle stream of argon gas using a 12-position NEVAP evaporator (Organomation Associates, Inc., Berlin, MA), and then vacuum pumped for >2
h. The resultant lipid films were hydrated in 10 mM HEPES pH 7.4. Small unilamellar vesicles
(SUVs) are produced by ultrasonication using a Sonic Dismembrator (3-mm micro tip, a total
duration of 10 min). To obtain LPS/POPC mixtures with different weight ratios, an appropriate
volume of the LPS stock solution was added to the POPC film. The mixture was repeatedly
vortexed and sonicated using a bath sonicator. The lipid suspension was later transferred to a 10mL glass beaker. Additional ultrapure water was supplied to the beaker so that the final volume
was ~5 mL. Small unilamellar vesicles (SUVs) were prepared using a Branson Ultrasonics Sonifier
SFX 250 and a 10-mm flat tip. The obtained SUVs were centrifuged briefly before planar bilayer
preparation to get rid of possible metal particles shredded from the sonicator tip. This obtained
solution was injected into the fluid cell, spreading over freshly cleaved mica as a substrate, via a
syringe pump.
Planar supported bilayer was formed after incubation of SUVs for 15-30 minutes by fusion.
The excess SUVs were flushed out with the appropriate buffer solution.
Another approach was used to prepare the bilayer outside of the fluid chamber for helix
H0 endophilin N-BAR domain experiments. Freshly cleaved mica was marked with a circle (6-8
mm diameter) at the center by a super pap pen liquid blocker from Ted Pella Inc. Redding, CA.
The SUV solution (60-100 µl) obtained after centrifugation was deposited within the marking in
mica and the assemblage was placed on dry heat block at ~37°C for 10 minutes to prepare bilayer.
The SUVs were attached and fused on the mica substrate which eventually coalesces to form a
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uniform supported bilayer. The excess SUV solution was gently exchanged with ultrapure water
(~80 µl) using a pipette (8-10 times). Keeping the bilayer hydrated at all the times, the mica was
transferred to the fluid chamber and replenished with appropriate buffer via a syringe pump.
2.2.3.5 Measurement process
AFM was used to scan the topographic images and acquire the force curve as discussed
below:
2.2.3.5.1Topographic
Topographic images of the samples were acquired either by using ScanAsyst-Fluid+ with
2-nm tip or DNP-S10 probe with a nominal tip radius of 10 nm. Squared images were acquired at
a scan rate of 0.5-1.0Hz. The maximum force or peak force was set at 300pN -400pN. After
obtaining several control images, we inject the solution with compounds of interest at specific
concentrations. This includes colistin, E107, Melittin, and helix H0 domain of endophilin in
ultrapure water. AFM images of a compound of interest-treated bilayers were acquired using the
same procedure as for the control bilayer. The obtained AFM images were leveled by subtracting
a polynomial background using in-house developed MATLAB scripts.
2.2.3.5.2Force measurement
In the region of interest, evenly spaced points were marked on a bilayer area of 4 μm × 4
μm. Force measurements were performed at each point using the automated force-ramping
function. The z-range for the force measurements was 100 nm; the approaching and retracting
speed of the AFM tip was 200 nm/s; the number of data points for each curve was 2560. One
parameter used to analyze the obtained force curves was the tip radius. The nominal tip radius was
20 nm for the ScanAsyst-Fluid probe. To obtain a more accurate estimation, we used the tip
quantification function provided by the Nanoscope Analysis software. The function estimates tip
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end radius by analyzing height images of a titanium characterizer sample (model RS-12M) that
contains many sharp grain features.
2.2.4 Bacterial studies
To investigate the effect of colistin on the gram-negative bacterial cells,
E. coli (ATCC 25922) obtained from Dr. Jianfeng Cai’s group in the Department of Chemistry,
USF, were used. These cells were grown in LB broth medium (Miller from Fisher Scientific). A
small aliquot (10 µl) of the stock sample (stored at -80C, after thawing) is pipetted into 60 ml LB
broth taken in 250 ml conical glass vessel. This vessel was loosely covered and placed in an
incubator (MaxQ 8000, Thermofisher Scientific, NY) at 37C, 120 rpm. Overnight grown bacteria
with optical density (OD600) ~1.0, measured by Nanodrop, were taken for experiment.

Figure 2.12 MaxQ 8000 incubator used to grow E.coli bacteria

We placed 200 µl of freshly grown bacteria in 800 µl of LB broth with appropriate colistin
concentration taken in 48 well microplate (Falcon polystyrene Microplates, Fisher Scientific,
Pittsburg, PA). This microplate was incubated at 37C in Heratherm incubator (Fisher Scientific,
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USA) equipped with a microplate shaker (Fisher Scientific, USA) at 120 rpm. The samples were
transferred to eppendorf tubes from the microplate and centrifuged to remove the broth. The pellet
was suspended in 1 ml ultrapure water, and 20 µl solution was deposited on freshly cleaved mica.
After complete drying at room temperature, samples were scanned with AFM in air. Topographic
images were acquired using the FMV-A probe scanned at 0.8-1 Hz scan rate with auto pick force
set point.

2.3

Conclusion
In this chapter, materials and methodologies used for the dissertation work are discussed.

Here we introduced the most frequently used instruments like spectrofluorometer, atomic force
microscopy and the micropipette aspiration of giant unilamellar vesicles. We also discussed the
theoretical background and general operating procedure of the aforementioned techniques.
Furthermore, we briefly discussed about the culture of E.coli cells along with sample preparation
procedure to observe the topographical changes induced by colistin using atomic force
microscopy.
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3.

PEPTIDOMIMETIC E107-3 EFFECT IN MODEL LIPID BILAYER1

In this chapter, we discuss the effect of a potential antimicrobial peptidomimetic, E107-3,
on lipid membrane. The effects in lipid bilayers’ structural and mechanical properties are studied
using vesicle leakage experiments, micropipette aspiration and supported bilayers by AFM. A
comparison effect of melittin is also performed. The part of this chapter is published earlier in
Biochim Biophys Acta in 2017 under Modulation of Lipid Membrane structural and Mechanical
properties by a Peptidomimetic derived from Reduced Amide Scaffold.

3.1

Introduction
Multidrug resistance of infectious bacterial pathogens is becoming an emerging health

problem worldwide. Small amphipathic antimicrobial peptides (AMPs) are nature’s ancient
antibiotics [49]. They possess a broad spectrum of antimicrobial activity and are less prone to
eliciting multidrug resistance. However, AMP-based antibiotics suffer from several limitations,
including immunogenicity and susceptibility to protease degradation [50]. Recently, creation and
development of non-natural oligomeric peptide mimics, the so-called peptidomimetics, have
become a field of large interest in biomedicine [51]. Examples include peptoids [52], βpeptides[53], γ- and δ-peptides [54], azapeptides[55], α-aminoxy-peptides [56], sugar-based
peptides [57], α/β-peptides [58], phenylene ethynylenes [59], and AApeptides [60, 61], to name a

1

This chapter is partially reproduced from a work published in a peer reviewed journal. The author of this
dissertation is the first author of the published work. See Appendix B for the permissions
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few. By introducing unnatural backbones, these oligomers are more stable against proteolysis and
are believed to have reduced immunogenicity [62].
Peptidomimetics containing reduced amide bonds have been shown to exhibit superb
resistance to enzymatic degradation [63]. The unique properties offered by reduced amide have
inspired a wave of interests in the field of biology and medicine [64-67]. We have recently
developed a library of small compounds based on the reduced amide scaffold (Figure 1.6A) [29].
All compounds share the same backbone. However, the four side groups vary regarding
hydrophobicity and charge state. Due to their amphipathic nature, the compounds are expected to
have antimicrobial activities similar to AMPs. Indeed, a lead compound referred to as E107-3
(compound 13 in ref [29]) was identified. E107-3 exhibits bactericidal activity against both Grampositive and Gram-negative microbes. The published preliminary study indicates that bacterial
membranes become permeable to propidium iodide after being treated with E107-3 [29]. It seems
that the compound acts by targeting and damaging bacterial membranes. Membrane damage
induced by AMPs can proceed with different mechanisms, such as pore formation and detergentlike membrane disintegration [31]. In this study, we are interested in elucidating detailed structural
and mechanical modulations of model lipid membranes imparted by E107-3.
We use vesicular and planar lipid bilayers in the study. To mimic the anionic nature of
bacterial membranes, we add 10 mol% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol
(POPG) to lipid bilayers formed by 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine
(POPC). We note that the lipid composition of bacterial membranes is far more complicated than
what we use here [68]. Therefore, the results we show in this study only represent an initial step
toward a more comprehensive evaluation of different lipid species, whose physicochemical
properties may be affected by the antimicrobial compound differently. Time-course and steady-
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state fluorescence spectroscopy measurements are performed to investigate dose- and timedependent membrane permeation induced by E107-3. The leakage experiment only provides
averaged response of unilamellar vesicles (ULVs). To explore the kinetic response of individual
giant unilamellar vesicles (GUVs), we use micropipette aspiration experiment [39, 43, 69-71].
Kinetic behavior of GUV area/volume is obtained by monitoring GUV protrusion length [40, 41,
72-74]. Solution atomic force microscopy (AFM) is used to visualize the impact of E107-3 on lipid
bilayer structures within a nanoscopic regime. Different modes of action by E107-3 and melittin
are obtained by comparing the resulting structures of planar lipid bilayers. In addition to providing
bilayer topographic information [75-78], AFM measurements can also be used to determine bilayer
mechanical properties [79-88]. We use AFM-based force spectroscopy to investigate bilayer
mechanical perturbation exerted by E107-3. Quantitative mechanical modulation is obtained by
determining the bilayer puncture force FP and the bilayer area compressibility modulus KA as a
function of E107-3 concentration. Our experimental results provide useful insights into the
molecular basis used by E107-3 in impairing lipid bilayer’s structural and mechanical integrity.
Such knowledge is useful for future optimization of antimicrobial peptidomimetics based on the
reduced amide scaffold.

3.2

Results

3.2.1 Calcein leakage
We first use time-dependent vesicle leakage to assess the effect of E107-3 on lipid bilayer
permeability. The control experiment with pure ULVs shows that no calcein leaks out during the
experimental time scale (Figure 3.1A). The control experiment is necessary because osmotic stress
caused by different salt concentrations in the interior and at the exterior of ULVs can artificially
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induce calcein leakage. The addition of 20 μM E107-3 results in a gradual increase of the
fluorescence signal, suggesting that E107-3 enhances lipid bilayer permeability; increasing E1073 to 30 μM yields a faster leakage behavior; the leakage rate is continuously increased by larger
concentrations of E107-3 (i.e., 60, 80, and 100 μM).

Figure 3.1 Time-course measurements of the fluorescence enhancement of calcein-enclosed
POPC/POPG ULVs exposed to different concentrations of E107-3 (A). A control
experiment without E107-3 is also displayed. Similar time-course measurements for
POPC/POPG ULVs exposed to the antimicrobial peptide melittin at four
concentrations(B).

For comparison, time-course measurements of the well-studied antimicrobial peptide
melittin are also shown (Figure 3.1B). [40, 73, 89]. For 0.1 μM melittin, almost no increase of the
fluorescence signal is observed over the 30-min incubation period; the increase of the fluorescence
signal becomes fairly significant over ~30 min for 0.2 μM melittin; near full leakage is achieved
within a few minutes for melittin ≥0.3 μM. Compared to E107-3, melittin seems to require much
lower concentration to cause acute calcein leakage. This implies that different mechanisms might
be utilized by the two agents to increase bilayer permeability.
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To study the leakage behavior over a longer period, we measure fluorescence spectrum of
calcein-enclosed ULVs incubated with different concentrations of E107-3 for ~20 h (Figure
3.2(1)).

Figure 3.2 Fluorescence spectra of calcein-enclosed ULVs incubated with different concentrations
of E107-3 for ~20 hours (1). Each spectrum is normalized by the maximum intensity of
ULVs treated with 20 mM Triton X-100. In panel 2, Bright field (A) and fluorescence (B)
images of an aspirated POPC/POPG GUV are shown. The protrusion length LP, the
micropipette inside diameter 2RP, and the GUV diameter 2RV are illustrated. Scale bars
are 10 μm.

The obtained spectra are normalized by the peak intensity at 514 nm for ULVs treated
with 20 mM Triton X-100. It is clear that full leakage is achieved for E107-3 ≥ 20 μM over the
20-h incubation period, whereas 5 μM E107-3 is only able to induce a small fraction of calcein
leakage.
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3.2.2 Micropipette aspiration of GUVs
Fluorescence spectroscopy-based leakage experiment only provides averaged response of
ULVs treated with insulting agents [32, 90]. We use micropipette aspiration of GUVs to obtain a
qualitative response of individual vesicles exposed to E107-3. Under a small constant negative
pressure, the GUV protrudes by a length LP into the micropipette (Figure 3.2(2)) The change of
LP is directly related to the change of the GUV area and volumetric properties.

Figure 3.3 Real-time response of an aspirated POPC/POPG GUV exposed to 5 μM E107-3. Scale
bars are 10 μm

Immediately after retracting the transfer-pipette from the micropipette in the reaction well
(marked as t=0 s), the kinetic response of the aspirated POPC/POPG GUV to 5 μM E107-3 is
shown in Figure 3.3. The GUV protrusion length LP increases spontaneously and reaches a
maximum value at ~7.5 s, after which the protrusion length decreases continuously. The GUV is
ruptured when the protrusion length diminishes to near zero. In addition to the change of the
protrusion length, Figure 3.3 shows that string-like structures emerge near ~9.0 s. These strings
are anchored to the inner leaflet of the GUV. Since they are visible under the fluorescence
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microscope, the strings contain Rh-DPPE lipids. Other features have been observed when GUVs
are exposed to membrane active molecules, such as tubules [91] and lipid clusters (or substances)
[72]. The formation of extra features (e.g., strings, tubules, and clusters) requires lipids derived
from GUVs. Therefore, our observation could indicate that E107-3 is able to extract lipid
molecules from the GUV bilayer.
We have performed the aspiration measurements for >30 GUVs. The majority of them
exhibit the similar trend of the protrusion length shown in Figure 3.3, i.e., LP increases and then
decreases followed by GUV rupture. However, the time point when the LP starts to decrease does
vary. This could be caused by variation of the initial suction pressure, the quality of the
micropipette, and GUV parameters (e.g., size). In a few cases, GUVs rupture before LP decreases
noticeably. These GUVs might have a “weaker” resistance to rupture.
Overall, the GUV aspiration experiment qualitatively shows that E107-3 binds to lipid
bilayers, resulting in a modulated protrusion length that first increases and then decreases as a
function of the incubation time. To gain a better understanding of the effects of E107-3 on lipid
bilayer physical properties, we use solution AFM experiments to characterize structural and
mechanical parameters of planar lipid bilayers within a nanoscopic regime
3.2.3 Solution atomic force microscopy
Solution AFM is used to visualize the effect of E107-3 on POPC/POPG lipid bilayer
structure. A mica-supported planar bilayer is first prepared in the AFM fluid cell. After bilayer
formation, excessive SUVs are flushed out by injecting buffer solution. During the bilayer
preparation process, the AFM tip is positioned at ~50 μm above the mica surface. AFM height
images are acquired by engaging the tip to different locations. The height image of the intact
bilayer is shown in Figure 3.4A. The height profile along the bilayer surface indicates that the
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surface roughness is ~0.1 nm. We note that the topographic structure of the planar bilayer is
uniform within the fluid cell. This is confirmed by scanning and comparing bilayer patches at
different locations. Bilayer uniformity is important when studying structural modulation induced
by E107-3 because the AFM tip is moved to different locations (to eliminate the influence of
repetitive scanning) to acquire height images and perform force spectroscopy measurements.

Figure 3.4 Solution AFM height images of a POPC/POPG bilayer exposed to incremental
concentrations of E107-3: 0 μM (A), 5 μM (B), 20 μM (C), and 100 μM (D). The bottom
row displays height profiles along the dashed lines highlighted in A–D. Scale bars are 100
nm
After image acquisition of the control bilayer at several locations (≥3), the AFM tip is
retracted, and a solution containing 5 μM E107-3 is injected. The bilayer is exposed to the 5 μM
E107-3 solution for ~30 min, after which the AFM tip is moved to a different location to acquire
the modified bilayer topography (Figure 3.4B). It is clear that the bilayer becomes rougher with
many higher and lower features. The height profile indicates that the bilayer roughness increases
to ~0.2 nm. The total reaction time between the bilayer and the 5 μM E107-3 is about 2 h. (Similar
amount of the reaction time is used for other concentrations of the compound.) During the ~2-h
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incubation period, we do not find noticeable changes of the bilayer topography (Figure 3.5). The
absence of kinetic modulation could indicate that bilayer perturbation imparted by E107-3
completes before the first scan is taken. To explore the effect of E107-3 at higher concentrations,
we inject a solution containing 20 μM E107-3 to replace the 5 μM solution. After equilibrating for
~30 min, the height image (acquired at a different location) is shown in Figure 3.4C. The
heterogeneous features observed at 5 μM E107-3 become more pronounced, accompanied by a
slightly larger bilayer roughness. Finally, we inject a solution containing 100 μM E107-3 to replace
the 20 μM solution. The topographic structure of the planar bilayer (acquired at a different
location) is furthered modified, although the surface roughness does not seem to increase (Figure
3.4D).

Figure 3.5 Solution AFM height images of a POPC/POPG bilayer exposed to 5 µM E107-3 for
different amount of times. The three images are acquired in sequence with a time interval
of ~ 40 min. Scale bars are 100 nm.

AFM height images reveal that E107-3 modifies lipid bilayer topography, but does not
produce pore-like structures. To support this statement, we expose a POPC/POPG bilayer to the
well-studied antimicrobial peptide melittin, which is known to form transmembrane pores (or
defects) [40, 89, 92]. After equilibrating with 0.4 μM melittin for ~30 min, the bilayer is perforated
with numerous pore-like defects (Figure 3.6). It is noteworthy that the maximum depth of the
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defects is smaller than the bilayer thickness (~3–4 nm) [93-95]. This is mainly related to the
geometry and size of the AFM tip (and scanning parameters such as tip speed) [89]. Nevertheless,
a comparison between Figure 3.4 and Figure 3.6 clearly shows that E107-3 and melittin disrupt
lipid bilayers by different mechanisms.

Figure 3.6 Solution AFM height image of a POPC/POPG bilayer before (A) and after (B) being
exposed to 0.4 μM melittin. Scale bars are 100 nm. The bottom row displays height profiles
along the dashed lines highlighted in (A) and (B).

The planar bilayer exposed to E107-3 does not contain transmembrane pores, but rather
resembles the fluctuation-like structures observed in ternary lipid mixtures [96, 97]. A correlation
length ξ was used to describe the length scale of the fluctuation-like structures [96, 97]. Correlation
length has also been used to characterize the length scale of critical fluctuations observed in GUVs
[98, 99]. Here we use the same concept of the correlation length to characterize the length scale of
the heterogeneous features induced by E107-3 (Figure 3.4). First, we calculate the height weighted
pair distribution function G(r) [99, 100]
𝐺(𝑟) = 〈ℎ(𝑟) × ℎ(𝑟 + 𝛿)〉 − 〈ℎ(𝑟)〉〈ℎ(𝑟 + 𝛿)〉
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(3.1)

where brackets denote ensemble average over the radial distance δ. Within a certain
distance range r, the pair distribution function G(r) decays exponentially [99, 100]. The
corresponding decay length is defined as the correlation length ξ. A similar calculation has been
performed by Connell et al. to show that the correlation length of planar lipid bilayers decreases
at elevated temperatures [97].

Figure 3.7 Height- weighted pair distribution functions G(r) for a POPC/POPG bilayer exposed
to different concentrations of E107-3. Linear fitting to the logarithm of G(r) gives rises to
the correlation length ξ, which is 5.1, 5.8, and 7.3 nm for 5, 20, and 100 μM E107-3,
respectively.

A qualitative description of the correlation length is that it is correlated with the distance
between nearest neighbors that have the same features in AFM height images Figure 3.7. shows
linear fits to the logarithm of the pair distribution functions G(r). The resulting correlation length
is 5.1, 5.8, and 7.3 nm for 5, 20, and 100 μM E107-3, respectively (uncertainty of ~3 nm). Close
examination indicates that at a fixed distance r, the pair distribution function is about one order of
magnitude smaller at 5 μM than at 20 and 100 μM E107-3. This is consistent with the trend of the
bilayer roughness as a function of the peptide concentration shown in Figure 3.4.
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3.2.4 AFM-based force spectroscopy
The obtained AFM height images indicate that E107-3 modulates lipid bilayer structure by
generating heterogeneous features. To study how E107-3 perturbs lipid bilayer mechanical
properties, we use AFM-based force spectroscopy. Force measurements are performed on the same
bilayer (but at different regions within the fluid cell) as the peptide concentration increases. Since
the same tip is used throughout the experiment, relative changes of the bilayer mechanical
properties derived from the force spectroscopy data can be unambiguously determined. Moreover,
the size of the determined correlation length of the modulated bilayer (Figure 3.4) is smaller than
the AFM tip size (~20 nm) used in force spectroscopy measurements. This means that each force
curve corresponds to an averaged measure of the heterogeneous bilayer. To gain good statistics,
(i) multiple force curves are measured at one bilayer region, (ii) force measurements are performed
at different bilayer regions (by manually moving the tip to different locations), and (iii)
experiments are repeated by using different bilayers. Overall, the trend of the force curves as a
function of the peptide concentration is very repeatable. However, for control bilayers prepared
from different runs, the magnitude of the maximum force that punctures the bilayer can vary up to
~0.4 nN. This variation is comparable to the change caused by E107-3 as shown later. To eliminate
the variation between different runs, the force spectroscopy data presented here correspond to the
experiment performed on one bilayer.
The schematic of a force spectroscopy measurement is illustrated in Figure 3.8. (We only
consider the tip force during the approaching process.) When the tip is far away from the bilayer
surface (step 1), the force experienced by the tip is zero (after subtracting a baseline). Once the tip
is near the bilayer surface, the tip force deviates slightly from zero due to non-steric interactions,
such as hydration and van der Waals interactions [101].
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Figure 3.8 Schematic of an AFM-based force spectroscopy measurement as the tip approaches a
planar lipid bilayer (A). An example of a tip force-position curve (B). The tip position z in
(B) is converted into tip-mica separation s, resulting in a tip force-separation curve (C).

The tip force increases continuously as the tip indents into the lipid bilayer, which deforms
elastically (step 2). A maximum force defined as the puncture force FP is reached right before the
bilayer fails (step 3). The puncture force reflects the mechanical stability that a bilayer can
withstand before being punctured by the AFM tip. After bilayer puncture, the tip rapidly moves
across a thin water layer that resides between the bilayer and the mica substrate [102, 103]. The
tip force increases drastically after touching the mica surface. The raw data from force
spectroscopy is the tip force (or cantilever deflection) and the vertical position z of the scanner.
For our data analysis, the scanner position z is converted into the mica-tip separation s (Figure 3.8)
[104].
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Force-separation curves (>300) at each concentration of E107-3 are shown in Figure 3.9A.
The tip force gradually increases when the separation becomes smaller than ~6 nm. To obtain the
position where bilayer puncture occurs, we bin the force curves into the two-dimensional space of
force and separation (Figure 3.10). The obtained probability indicates that at 0 μM E107-3, the
puncture force occurs at s of 3.4–4.5 nm. The distance between the point where the force starts to
increase (i.e., force onset) and the point where the bilayer is punctured is slightly less than the
reported POPC or POPG bilayer thickness (~3–4 nm) [93-95]. This could be explained by
considering that bilayer puncture occurs before the apex of the tip reaches the bottom of the
supported bilayer. Such a consideration is reasonable since the tip end radius is ~20 nm, which is
much larger than the distance between the nearest lipid chains (~1 nm). Similar positions of the
force onset and bilayer puncture are observed when the concentration of E107-3 increases (Figure
3.10). This indicates that the supported bilayer is not disintegrated and remains stable after being
exposed up to 100 μM E107-3. Our result is in contrast to the effect of ethanol, which shifts the
positions of the force onset and bilayer puncture to smaller s [101].
The puncture force is correlated with bilayer stability. However, its magnitude is affected
by many factors, including buffer condition, sample preparation protocol, tip selection, and
parameters used for force measurements. Large variation of bilayer puncture forces has been
reported by different groups (from <1 nN to >10 nN) [81, 82, 86, 87, 101, 105-111]. For the
POPC/POPG bilayer in this study, the probability distribution of FP indicates that the most
probable FP is 2.8 nN (Figure 3.9B). The most probable FP remains the same at 5 μM E107-3, and
decreases slightly to 2.6 and 2.4 nN at 20 and 100 μM E107-3, respectively. Considering the widths
of the puncture force distributions (FWHM is 0.40, 0.15, 0.21, and 0.18 nN for 0, 5, 20, and 100
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μM E107-3, respectively), the change of FP induced by E107-3 is relatively small. This highlights
that the mechanical stability of the lipid bilayer is not markedly altered by E107-3.

Figure 3.9 Force-separation curves of a POPC/POPG bilayer exposed to incremental
concentrations of E107-3. Each panel is a superposition of >300 curves. (A) Probability
distributions of the puncture force FP determined from force-separation curves. Solid lines
are Gaussian curve fitting (B). An example of model fitting to force-separation curves at
different peptide concentrations (C).
.
In addition to the puncture force, other mechanical properties of the lipid bilayer can be
inferred from the obtained force-separation curves. In the elastic deformation regime of the lipid
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bilayer, the tip force is dominated by stretching of lipid molecules near the tip. Free energy
calculation of a tension-free lipid bilayer results in a quadratic relationship between the tip force
and the tip-mica separation s [103]:

𝐹 = 𝜋𝐾𝐴 𝑅 (

𝐷−𝑠 2
)
𝑠

(3.2)

where KA is the lateral area compressibility modulus of the lipid bilayer, R is the tip end
radius, and D is the bilayer thickness.
The equation assumes that the thickness of the water layer between the bilayer and the mica
surface is zero. For non-zero water layer thickness, D is a combination of the thicknesses of the
bilayer and the water layer. Using equation (3.2) and the obtained force spectroscopy data, we are
able to determine the change of the lipid bilayer’s mechanical property (i.e., KA) after being
exposed to E107-3.
An example of the elastic model fitting is shown in Figure 3.9C. It is clear that good
agreement is obtained between the theoretical prediction and the force spectroscopy data. Two
criteria are used to determine the region for data fitting: (i) the tip force is no larger than 80% of
the puncture force FP (the cut-off force), and (ii) the largest tip-mica separation s is 6.2 nm (the
cut-off position). The first criterion is based on the observation that many force curves deviate
from the quadratic function when the force approaches FP; the second criterion is related to the
fact that the equation is only valid within a regime where the lipid bilayer deforms elastically.
Nevertheless, we find that the effect of the cut-off position is minimal, whereas an increase of the
cut-off force to 90% of FP decreases KA by ~8%. It has shown that the attractive force between the
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mica and the tip is near zero in a fluid when s is larger than 2 nm [112]. Therefore, the influence
of the mica substrate is negligible for our data fitting using the elastic deformation model.

Figure 3.10 Probability distributions of force-separation curves shown in Figure 3.9. The
probability of each panel is obtained by binning >300 curves into two-dimensional grids.
For a fixed separation s, the probability (along F direction) is normalized by the maximum
probability at that separation s.

Using equation (3.2) and the two cut-off criteria, we analyze all the force curves shown in
Figure 3.9A. The results are summarized in Table 3-1 The obtained KA is 246 ± 19 mN/m for the
control bilayer. This value is in good agreement with the reported value for a POPC bilayer
obtained from micropipette aspiration [113]. Bilayer elastic parameters can also be evaluated using
molecular dynamics (MD) simulations. The reported KA from the simulation work is smaller for
POPG than for POPC bilayers [114]. Since the POPC/POPG bilayer we use contains 10 mol%
POPG, our KA may not exactly correspond to that of a pure POPC bilayer.

Table 3-1 Concentration-dependent effect of E107-3 on lipid bilayer nanomechanics. The bilayer
area compressibility modulus KA is determined from AFM-based force spectroscopy data

107-3(µM)
KA(mN/m)

0
246±19

5
202±24
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20
182±21

100
151±18

To explore the impact of E107-3 on the elastic property of planar lipid bilayers, we perform
force spectroscopy measurements after exposing the bilayer to incremental concentrations of
E107-3. The obtained force curves are analyzed using the elastic bilayer deformation model
(equation 3.2). The resulting KA is 202 ± 24, 182 ± 21, and 151 ± 18 mN/m at 5, 20, and 100 μM
E107-3, respectively. Equation (3.2) shows that the determined KA is stringently associated with
the tip radius R; therefore, the uncertainty of the tip radius contributes as the primary source for
the uncertainty of KA [103]. However, since the same tip is used for the force spectroscopy
measurements, the values of KA in Table 3-1 unequivocally show that E107-3 decreases KA of the
planar bilayer.
3.2.5 Double-bilayer structure in the presence of calcium ions
In addition to modulating bilayer physical properties, AMPs can also impair lipid bilayers
by extracting lipids from the bilayer environment [31]. In the presence of fusogenic agents, the
extracted lipids may associate together and spontaneously form a second bilayer on top of the
original bilayer (i.e., a double-bilayer architecture mimicking the pre-fusion contact state [115]).
We use calcium ion as a fusion promoter [116] to test whether E107-3 can extract lipid molecules
from planar bilayers. The experimental procedure is very similar to solution AFM measurements
presented in the section of Materials and Methods. The main difference is that force spectroscopy
measurements are performed on the same bilayer after obtaining an AFM image. After forming a
POPC/POPG bilayer in the AFM fluid cell, we remove excessive vesicles and then inject a buffer
solution containing 5 mM CaCl2 and 10 mM HEPES pH 7.4. Solution AFM imaging and force
spectroscopy measurements show that a single bilayer is formed (Figure 3.11). We later add 50
μM E107-3 in 5 mM CaCl2 and 10 mM HEPES pH 7.4 to the preformed planar bilayer. After
incubating for ~40 min, the resulting AFM image containing two distinct regions is shown
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in Figure 3.12. Height discontinuity at the region boundary indicates that the two regions have a
height difference of ~5.5 nm Figure 3.12 This value is close to the total thickness of a lipid bilayer
and an inter-bilayer water layer [117]
To validate the formation of a double-bilayer structure, we perform force spectroscopy
measurement. It is found that the lower region (region a) has a single puncture event located at a
separation s of ~3.5 nm (Figure 3.12C). Conversely, the higher region (region b) exhibits two
puncture events located at a separation s of ~3.5 nm and ~8.1 nm, respectively. The force onset
position corresponding to the two puncture events is located at s of ~5.6 nm and ~11.0 nm,
respectively.

Figure 3.11 Solution AFM height image of a POPC/POPG bilayer in 5 mM CaCl2 and 10 mM
HEPES pH 7.4. Scale bar is 0.6 µm (A). Force spectroscopy data for the bilayer in (A). A
single puncture event is seen at a separation s of ~4.1 nm and a puncture force FP of ~2.2
nN (B)

These two values correspond well to the surface positions of mica-supported single and
double bilayers [76]. Moreover, similar two-puncture events have been observed for doublebilayer membranes [118]. Based on the similar shape of the two force curves located at ~3.5–5.6
nm and ~8.1–11.0 nm (Figure 3.12C), as well as the height difference between the two regions
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(Figure 3.12B), it is clear that the higher region corresponds to a double-bilayer structure, while
the lower region corresponds to a single-bilayer structure. Formation of a second bilayer on top of
the mica-supported bilayer requires lipid molecules that can only be supplied by the original
bilayer (i.e., the mica-supported bilayer); therefore, our double-bilayer experiment demonstrates
that E107-3 can extract lipids from planar bilayers.

Figure 3.12 A POPC/POPG bilayer treated with 50 μM E107-3 in the presence of 5 mM CaCl2.
(A) Solution AFM height image. Two regions with distinct heights are highlighted as
region a and b. Scale bar is 0.6 μm (B) Height profiles along the dashed lines indicated in
(A). A height discontinuity is seen when the horizontal lines cross the boundary of the two
regions. (C) Force spectroscopy data for the region a and b, respectively. Only one
puncture event is observed for the region a, while two puncture events are observed for the
region b.
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Another piece of evidence supporting the role of lipid extraction by E107-3 is that similar
double-bilayer structure using AFM imaging and force spectroscopy measurements are obtained
when we expose POPC/POPG bilayers to the antimicrobial peptide daptomycin in the presence of
calcium ions (unpublished data). Since it has been shown that daptomycin functions by extracting
lipids [72], it is reasonable to argue that E107-3 can work in a similar way. Relating to the lipid
extraction effect, one interesting question is which lipid (i.e., POPC or POPG) in our system is
more prone to be extracted. As mentioned earlier, the two force curves corresponding to the
double-bilayer structure have similar shapes (Figure 3.12C). This means that the physical
properties of the two bilayers are similar. Since the original bilayer is composed of POPC and
POPG, it is plausible that the newly formed bilayer contains both POPC and POPG, i.e., both
POPC and POPG can be extracted by E107-3. Regarding the mechanism of the formation of a
second bilayer, calcium ions promote the fusion propensity of extracted lipids; therefore, the
extracted lipids by E107-3 can spontaneously deposit onto an existing surface (i.e., the original
bilayer). This process has some similarity to the planar bilayer formation on a mica surface using
SUVs.

3.3

Discussion
In this study, we use a combination of experimental approaches to interrogate the molecular

mechanism of a recently synthesized antimicrobial compound based on acylated reduced amide
scaffold. The compound referred to as E107-3 has been demonstrated to exhibit promising
antimicrobial property with a minimum inhibitory concentration <10 μM for both Gram-positive
and Gram-negative microbes [29]. We specifically focus on how E107-3 impairs lipid membrane
structural and mechanical integrity.
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Using fluorescence spectroscopy-based calcein leakage experiment, we show that E107-3
perturbs lipid bilayer structure, yielding defects that allow calcein to permeate through the
hydrophobic barrier. Vesicle leakage rate is dependent on the concentration of E107-3. The
majority of the leakage occurs within the first few hours for concentrations ≥ 20 μM, whereas 5
μM of E107-3 is only able to induce a minuscule fraction of calcein leakage after incubation of
~20 h. Compared to melittin, which causes acute vesicle leakage at <1 μM, E107-3 may perturb
lipid bilayer properties through a mechanism that is different from transmembrane pore formation.
The kinetic response of individual vesicles to the treatment of E107-3 is qualitatively
illustrated by the micropipette aspiration experiment. We find that the protrusion length of the
aspirated GUV first increases and then decreases to near zero before the vesicle ruptures. The
increase of the protrusion length most likely corresponds to the initial binding of E107-3 to the
GUV surface. Both the hydrophobic side groups and the cationic characteristic of E107-3 (Figure
1.6) could promote the bilayer-binding process. Surface binding may not immediately induce the
formation of bilayer defects; thus, no solutes are exchanged between the interior and exterior of
the GUV (i.e., constant GUV volume). To accommodate the increase of the surface area, a fraction
of the GUV protrudes into the micropipette. This explains the increase of the protrusion length
during the first ~8-s period.
After reaching a maximum value, the protrusion length spontaneously decreases to near
zero. Two possibilities could account for the behavior [40, 72, 74, 92]. The first one involves an
invariant GUV surface area, while the GUV volume increases (by processes such as solute influx
through finite-sized defects); the second one considers a constant GUV volume but the surface
area decreases. A common scenario corresponding to the second possibility is lipid extraction from
GUV bilayers [72, 74]. Our leakage experiment suggests that E107-3 can increase the bilayer
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permeability to calcein. Therefore, it is plausible that exposure to E107-3 allows glucose/water
molecules to translocate from the exterior to the interior of the GUV, thus increasing the GUV
volume and decreasing the protrusion length. Solute influx, however, does not necessarily mean
the formation of steady pores by E107-3, since transient defects also allow solutes to permeate
through the bilayer. Lipid extraction accompanied by the decrease of the protrusion length has
been observed for a broad spectrum of molecules [72, 74, 91]. We confirm the role of E107-3 in
extracting lipids from planar bilayers by observing a double-bilayer structure in the presence of
fusogenic calcium ions. Collectively, the decrease of LP for aspirated GUVs is likely caused by
two mixed processes of bilayer permeation and lipid extraction.
We use 5 μM E107-3 for the aspiration experiment. For a typical GUV with a diameter of
40 μm, the number of lipid molecules that the GUV contains is ~1.5 × 1010 (lipid area ~0.65
nm2 for POPC and POPG [93, 94]). When the GUV is submerged in 200 μL of 5 μM peptide
solution, the estimated peptide to lipid ratio (P/L) is 4.0 × 104. This value is much larger compared
to the P/L values used in the leakage experiment (P/L ~1 for 100 μM peptide). The different P/L
values may account for the different kinetic responses in the aspiration and leakage experiments.
We note that although the P/L value is large in the aspiration experiment, only a portion of the
peptide molecules will be able to interact with the GUV within the time scale of Figure 3.3. This
is illustrated by the root mean square displacement of glucose molecules. It takes ~33 s for glucose
to travel by 200 μm in water (diffusion coefficient ~600 μm2/s [119]). Therefore, for the time scale
of the aspiration experiment, only a shell of peptide molecules surrounding the GUV will be able
to interact with the GUV bilayer. Such a consideration will decrease the effective P/L in the
aspiration experiment.
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We use solution AFM to determine the effects of E107-3 on nanoscopic structural and
mechanical properties of planar lipid bilayers. AFM height images reveal that E107-3 and melittin
perturb lipid bilayers differently. Specifically, melittin perforates lipid bilayer by forming porelike structures, while E107-3 only mildly increases the bilayer roughness by generating
heterogeneous features that have a correlation length ξ of ~5–7 nm.
To further explore the impact of E107-3 on lipid bilayer mechanical properties, we use
AFM-based force spectroscopy. We find that E107-3 only slightly decreases the bilayer puncture
force even at 100 μM. This behavior is in contrast to the marked decrease of the bilayer puncture
force when melittin is added (data not shown). The disparity further supports that E107-3 and
melittin act by different mechanisms. We also analyze the force spectroscopy data by using an
elastic deformation model. The bilayer area compressibility modulus K A is found to decrease
continuously from 246 to 150 mN/m when the concentration of E107-3 increases from 0 to 100
μM. The large decrease of KA (by 39%) contrasts with the mild decrease of the bilayer puncture
force. This indicates that KA might be a more suitable parameter to describe the impact of E107-3
on lipid bilayer mechanical integrity.
To explain our experimental data, we propose a bilayer interaction model illustrated
in Figure 3.13. E107-3 contains one cationic group (R1) and three hydrophobic groups (R2, R3,
and R4) (Figure 1.6). After binding to the bilayer surface facilitated by electrostatic and
hydrophobic interactions, the hydrophobic groups of E107-3 will insert into the hydrocarbon chain
region. Inter-leaflet redistribution of the compound can be achieved by the flip-flop mechanism
[120]. Due to the bulky adamantyl and phenyl groups of E107-3, the cohesive interaction between
lipid chains is likely perturbed. Moreover, the compound only has ten atoms (carbon and nitrogen)
along the backbone; therefore, its length is likely to be less than the thickness of one lipid
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monolayer, potentially inducing vacancies within the hydrophobic core. Similar vacancies have
been observed in simulations when coiled-coil peptides insert into lipid bilayers [121]. The
peculiar architecture of E107-3 may cause rearrangement of neighboring lipids in both leaflets
(Figure 3.13), resulting in a rougher bilayer as suggested by our AFM images (Figure 3.4). Local
defects are formed by impaired lipid chain packing in the vicinity of the compound. The disrupted
lipid chain packing enhances bilayer permeability, allowing small molecules (e.g., sugars and
calcein) to translocate across the hydrophobic barrier. This explains our vesicle leakage data and
serves as a potential mechanism (i.e., influx of solutes) for the behavior of the protrusion length
LP observed in our aspiration experiment.

Figure 3.13 A schematic diagram of bilayer disruption induced by E107-3. The lipid bilayer is
composed of a mixture of POPC (cyan head) and POPG (green head) lipids. The
amphipathic nature of E107-3 is illustrated by the green (hydrophilic) and brown
(hydrophobic) colors. The insertion of E107-3 into the lipid bilayer causes rearrangement
of neighboring lipids in both leaflets, resulting in a corrugated bilayer containing local
defects that allow small molecules to permeate through the hydrophobic barrier. E107-3
can redistribute between the two leaflets by flip-flopping. The perturbation of bilayer
integrity imparted by E107-3 is exacerbated by lipid extraction from the bilayer
environment.
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In addition to the perturbation within the bilayer plane, our double-bilayer experiment
shows that E107-3 can extract lipids from the bilayer environment. The lipid extraction effect of
E107-3 is also consistent with the decrease of the protrusion length LP observed in the GUV
aspiration experiment. Moreover, lipid extraction contributes to the enhanced bilayer permeability
observed in the calcein leakage experiment. Finally, we note that in addition to the hydrophobic
groups, the cationic group of E107-3 may also contribute to the perturbation exerted on lipid
bilayers. This is supported by theoretical calculation showing that electrostatic interaction
increases the rate of tension-induced pore formation in lipid bilayers [122].
The viability of microbes is critically dependent on the structural and mechanical integrity
of their membranous envelope. Our leakage experiment reveals that lipid bilayer permeability is
increased by E107-3. Therefore, modulation of membrane permeability could be one mechanism
employed by E107-3 in killing bacteria. Our force spectroscopy data show that E107-3 alters lipid
bilayer mechanical properties by decreasing the bilayer puncture force and the area compressibility
modulus. In line with our findings, a recent report by Henderson et al. showed that many
antimicrobial peptides share a common capability of reducing the interfacial line tension of lipid
membranes, resulting in impaired lipid membrane integrity [123]. Similarly, reduction of lipid
bilayer bending rigidity has been observed for an array of AMPs, including alamethicin [124-126],
melittin [127], and magainin [128]. Membrane material properties are essential to proper functions
of many membrane proteins [129]. Therefore, E107-3 could also act by impairing bacterial
membrane mechanical integrity. The two mechanisms could work synergistically. For example,
weakened membrane mechanical properties could result in a larger probability of forming transient
defects, thus increasing membrane permeability.
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3.4

Conclusions
Here we report the effects of an antimicrobial peptidomimetic (i.e., E107-3) on structural

and mechanical properties of POPC/POPG lipid bilayers. The compound was recently synthesized
based on the acylated reduced amide scaffold and has been shown to exhibit good antimicrobial
potency. Time-course and steady-state fluorescence spectroscopy measurements reveal that E1073 induces membrane defects that allow calcein to permeate through the hydrophobic barrier.
Compared to the bee venom antimicrobial peptide melittin, the leakage efficacy of E107-3 is two
orders less, implying that disparate antimicrobial mechanisms might be used by the two agents.
To obtain the kinetic response of individual GUVs exposed to E107-3, we use fluorescence
microscopy-based micropipette aspiration experiment. We find that the protrusion length of the
aspirated GUV first increases and then decreases to near zero. GUVs are ruptured once the
protrusion length diminishes. The increase of the protrusion length is likely caused by initial
surface binding of E107-3, resulting in GUV area expansion, whereas the decrease of the GUV
protrusion length could be due to solute/water influx and/or lipid extraction. We use solution AFM
to study the impact of E107-3 on nanoscopic structures of planar lipid bilayers. We find that unlike
melittin, which produces pore-like structures, E107-3 only slightly increases the roughness of the
lipid bilayer surface. We use a correlation length to characterize the length scale of the
heterogeneous structures induced by E107-3. The correlation length ξ is found to be ~5–7 nm.
Finally, we use AFM-based force spectroscopy to determine lipid bilayer mechanical properties.
We find a moderate decrease of the lipid bilayer puncture force FP as the concentration of E107-3
increases from 0 to 100 μM. We next apply a bilayer elastic deformation model to analyze the
obtained force spectroscopy data. We find that the bilayer area compressibility modulus KA is 246
mN/m for the POPC/POPG bilayer; KA decreases to 202, 182, and 151 mN/m at 5, 20, and 100
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μM E107-3, respectively. To test the effect of lipid extraction by E107-3, we use a method
involving double-bilayer formation. In the presence of calcium ions, a double-bilayer structure is
obtained (by AFM imaging and force spectroscopy measurements) after adding E107-3 to a
preformed POPC/POPG bilayer. Since the formation of a second bilayer requires lipid molecules
that can only be provided by the original bilayer, our double-bilayer experiment demonstrates that
E107-3 can extract lipids from planar bilayers. Together, our experimental data unambiguously
show that E107-3 impairs lipid bilayer structural and mechanical integrity. The observed
modulations are useful to elucidate the molecular mechanism used by E107-3 in killing bacteria
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4. INTERACTION OF COLISTIN WITH LPS CONTAINING BILAYER AND E.COLI
BACTERIA2
This chapter discuss about the permeability of the membrane depending on LPS content as
the effect of antimicrobial peptide colistin. It also describes the micro and macro-cluster of lipids
induced by colistin on LPS containing bilayer as well as effect of divalent cation Mg2+ in cluster
formation. Part of this chapter is published previously in ACS omega under the title
‘Lipopolysaccharide -Dependent Membrane Permeation and Lipid Clustering Caused by Cyclic
Lipopeptide Colistin.‘ in 2018.

4.1

Introduction
Polymyxins (A–E) belong to a group of cyclic lipopeptides with potent antimicrobial

characteristics [130]. Figure 1.7 shows that the heptapeptide ring of polymyxins is enriched with
the unusual cationic diaminobutyric acid (DAB); the C-terminus of the exocyclic tripeptide is
fused to the macrocyclic ring, while the N-terminus is linked to a fatty acid tail (prominently 6methyl-octanoic acid). Colistin known as polymyxin E was initially derived from the Grampositive bacterium Bacillus colistinus. Colistin is effective at a few micromolar concentrations to
inhibit bacterial growth or kill bacteria. Polymyxins, primarily polymyxin B and colistin, were
used as broad-spectrum antibiotics for clinical application starting in the 1950s. Later clinical
experiences showed that polymyxin-treatment was often accompanied with neurotoxic and

“Reproduced with permission from Khadka, N.K., C.M. Aryal, and J.J. Pan, Lipopolysaccharide-Dependent
Membrane Permeation and Lipid Clustering Caused by Cyclic Lipopeptide Colistin. Acs Omega, 2018. 3(12): p.
17828-17834.Copyright 2018 American Chemical Society
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nephrotoxic effects, although the toxicity was reversible upon discontinuation of the drug usage
[131]. The potential toxicity rendered polymyxins less desirable compared to other antibiotics. The
usage of polymyxins was gradually abandoned in the early 1980s. Recently, multidrug-resistant
(MDR) bacterial pathogens, mostly Gram-negative species such as P. aeruginosa, A. baumannii,
and K. pneumoniae, have emerged as a great health threat. Because of their potent antimicrobial
activities and low susceptibility to bacterial resistance, polymyxins have received a renewed
interest in combating MDR infections [132, 133]. In particular, polymyxins are currently used as
last-resort drugs to treat infections (e.g., cystic fibrosis) caused by microbes that are resistant to
almost all available antibiotics [134, 135].
The envelope of Gram-negative bacteria has a complex multi-layered architecture,
including the outer membrane (OM), the cytoplasmic membrane, and a peptidoglycan layer
located at the periplasmic space [136]. The OM of Gram-negative bacteria forms a permeability
barrier that is essential to bacterial viability. The OM has an asymmetric organization; the outer
monolayer is mainly composed of lipopolysaccharides (LPS), while the inner leaflet is formed by
phospholipids. Compared to phospholipids, polyanionic LPS molecules are better suited for
intermolecular interactions to form a supramolecular organization. Structurally, LPS can be
divided into three regions: an amphipathic lipid A moiety, a hydrophilic oligosaccharide core
(including the inner and outer cores), and an O-antigen chain. It is believed that strong
intermolecular interactions of LPS bridged by divalent cations (e.g., Mg2+ and Ca2+) are the
primary mechanism of enhancing the OM stability and limiting the permeation of external agents
such as lipophilic antibiotic compounds [137, 138].
Polymyxins have a high affinity for LPS molecules [139-142]. This is exemplified by the
antiendotoxic effect of polymyxins in treating septic shock caused by free LPS molecules (also
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known as endotoxins) [143]. The strong association of polymyxins with LPS also explains the
formation of rod-shaped projections from the cell wall of Gram-negative bacteria when exposed
to polymyxin B [144]. Although the exact mechanism underlying polymyxin functioning against
Gram-negative bacteria remains an open question, impairment of the LPS layer is believed to play
a crucial role in initiating the bactericidal activity. Polymyxin binding will cause the displacement
of divalent cations that are important for stabilizing the LPS layer by linking phosphates of
neighboring LPS molecules. A weakened LPS layer will allow more polymyxins (and other
solutes) to traverse the OM [145, 146]. The mechanism was coined as the self-promoted uptake
pathway [145]. Collectively, the first step of polymyxin functioning is to modify the structure and
organization of the LPS-enriched OM bilayer. Subsequent bactericidal activity can be carried out
by different mechanisms that are still not fully understood. A few of the proposed bactericidal
mechanisms include the perforation of the cell wall [147], formation of molecular contacts
between the OM and the cytoplasmic membrane [148], loss of enzymatic components [149, 150],
and production of reactive oxygen species [151].
To elucidate the effect of polymyxins on the OM bilayer, many studies have used LPScontaining vesicles or monolayers. A selective examples include (i) electron microscopy showed
that colistin disintegrated ribbon-like vesicular structures formed by isolated LPS [152]; (ii)
electron spin resonance revealed that polymyxin B had a large impact on the packing property of
LPS [153]; (iii) polymyxins inserted into LPS monolayers at the air-water interface as evidenced
by an increase in the surface pressure [154, 155]; (iv) electrophysiological measurements showed
that polymyxin B induced electrically active lesions in LPS-containing bilayers [156, 157]; (v)
nuclear magnetic resonance (NMR) coupled with computational modeling were used to predict
the molecular binding mode of polymyxin B and LPS molecules [158-160].
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In contrast to the abundant studies of polymyxins interacting with LPS in vesicular or
monolayer systems, only a few reports of polymyxin-LPS interactions in a planar bilayer setup
have been made. A recent study used LPS/phospholipid mixtures (and deep rough LPS) to prepare
oriented multilamellar stacks to mimic the OM bilayer; the authors then used X-ray diffuse
scattering to explore the effect of colistin on mechanical properties of the LPS-containing bilayers
[161]. Here we used solution atomic force microscopy (AFM) to investigate the effect of colistin
on nanoscale topographic structures of LPS-containing lipid bilayers. Our AFM-based study is
motivated by the facts that (i) AFM is a suitable technique to visually detect structural changes of
lipid bilayers induced by membrane-active compounds and (ii) only two AFM-based studies have
been reported on polymyxins interacting with LPS; one study was performed on a lipid A
monolayer [162] and the other used biotinylated LPS to form a monolayer supported by a densely
packed avidin layer [163].
In this studies, we first used vesicle leakage experiment to study changes in bilayer
permeability caused by colistin. The obtained results revealed that colistin-induced bilayer
permeation was dependent on the LPS fraction in LPS/phospholipid bilayers. We then used
solution AFM to explore structural changes of planar lipid bilayers. Our AFM measurements
showed that the effect of colistin on bilayer topographic structure was dependent on the LPS
fraction and the peptide concentration. Importantly, we observed nanoscale clusters that are
consistent with the complex formation of colistin and LPS molecules. The segregated lipid clusters
could produce membrane lesions (i.e., cluster edges) that are consistent with our vesicle leakage
data. We also found that both bilayer permeabilization and cluster development were inhibited by
introducing magnesium ions into LPS-containing lipid bilayers. Results from our vesicle leakage
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and solution AFM experiments provided useful insights into the mechanism that could be used by
polymyxins in impairing the permeability barrier of the OM of Gram-negative bacteria.

4.2

Results

4.2.1 Vesicle leakage

Figure 4.1 Vesicle leakage induced by colistin as a function of the peptide concentration. Vesicles
were prepared at several weight ratios of LPS/POPC. Vesicles with 5 mM MgCl 2 both
inside and outside was used to examine the effect of magnesium ions. The measurements
were performed after incubating vesicles with colistin for 20 h. Leakage of 0% corresponds
to control vesicles, and leakage of 100% corresponds to the treatment with 20 mM Triton
X-100.

We used fluorescence spectroscopy to examine the effect of colistin on bilayer
permeability. Lipid vesicles were prepared at several LPS/POPC weight ratios. Note that because
the molecular weight of the isolated LPS is unknown, we use weight ratios for LPS/POPC bilayers
in this study. Calcein-enclosed lipid vesicles were prepared by gel filtration. Fluorescence signal
from control vesicles is small due to the self-quenching property of the fluorophore (i.e., calcein).
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When colistin binds to lipid vesicles, the resulting increase in the bilayer permeability will cause
an increase in the fluorescence signal. We have previously used this method to evaluate changes
in bilayer permeability caused by different compounds [104, 164, 165].
Here we used vesicle leakage to measure changes in the bilayer permeability after
incubating lipid vesicles with colistin for 20 h. The result is summarized in Figure 4.1. For the
LPS-absent POPC vesicles, a maximum permeability increase of ~10% was observed. The
addition of LPS at 1:100 yielded a maximum permeability of ~30% (10 µM colistin). A further
increase of the LPS/POPC weight ratio to 1:30 and 1:10 resulted in a maximum permeability of
~55% (10 µM colistin). By comparing the maximum leakage % for LPS/POPC bilayers with
different LPS fractions, we conclude that colistin-induced bilayer permeation is dependent on the
LPS fraction.

Figure 4.2 Solution AFM images of an LPS/POPC 1:60 bilayer before (a) and after (b) exposure
to 10 µM colistin. Height scale is indicated by the color at the bottom. The same color bar
is used for all AFM images in the study. Scale bars are 200 nm. (c) Height profile along
the solid green lines in (a) and (b).
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In addition, because the maximum leakage % is <100% for all LPS/POPC bilayers studied,
we conjecture that only a portion of the fluorophore molecules was released from lipid vesicles
even when the maximum leakage was achieved. This indicates that colistin did not completely
damage lipid vesicles as the surfactant Triton X-100 would. Lastly, we examined the effect of
divalent cationic magnesium ions on bilayer permeabilization. This is done by preparing
LPS/POPC 1:30 vesicles with 5 mM MgCl2 both inside and outside. Figure 4.1 shows that the
magnesium ions significantly suppressed the maximum leakage % such that the LPS/POPC 1:30
vesicles suspended in 5 mM MgCl2 responded similarly to colistin as the POPC vesicles did.
Therefore, magnesium ions abrogated the effect of LPS in enhancing bilayer permeabilization
caused by colistin.

Figure 4.3 Solution AFM images of an LPS/POPC 1:60 bilayer before (a) and after (b) exposure
to 10 µM colistin; solution AFM images of an LPS/POPC 1:30 bilayer before (c) and after
(d) exposure to 10 µM colistin. Height scale is 5 nm. Scale bars are 1 µm.
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4.2.2 AFM experiment on planar lipid bilayers
We conducted solution AFM measurements to visually detect nanoscale structural changes
of LPS/POPC bilayers induced by colistin. Figure 4.2 shows the AFM images of an LPS/POPC
1:60 bilayer before and after exposure to 10 µM colistin. The control bilayer exhibited a
macroscopically homogeneous organization. The smooth surface structure is also indicated by the
height profile along the bilayer surface (Figure 4.2c). After confirming the quality of the control
bilayer, we used a syringe pump to inject a 10 µM colistin solution. Figure 4.2b shows the modified
bilayer structure after exposure to 10 µM colistin. Numerous small clusters with a length scale of
~20 nm were observed. Larger clusters with a length scale up to a few hundred nanometers were
also present at several locations. For simplicity, we will refer to the smaller clusters as "nanoclusters", and the larger clusters as "macro-clusters" or "clusters". AFM is sensitive to the bilayer
normal dimension. The height profile along an arbitrary path showed that the macro-clusters have
a height of ~2 nm above the background. The height of the nano-clusters is not well-defined by
the height profile because the path does not always coincide with the center of the nano-clusters.
Nevertheless, the nano-clusters have a height of ~1–2 nm as evidenced by the height profile.

Figure 4.4 Solution AFM images of an LPS/POPC 1:30 bilayer exposed to 5 µM (a) and 10 µM
(b) colistin. Height scale is 5 nm. Scale bars are 1 µm.
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After obtaining the preliminary data of bilayer restructuring, we are interested in the effect
of the LPS fraction in regulating colistin-induced lipid clustering. We used AFM imaging to
explore bilayer remodeling induced by colistin at two LPS fractions. Figure 4.3 shows the AFM
images of two LPS-containing bilayers (i.e., LPS/POPC of 1:60 and 1:30) before and after
treatment with 10 µM colistin. Dispersed clusters with a length scale of a few hundred nanometers
were observed for the LPS/POPC 1:60 bilayer (Figure 4.3b). (Note that Fig. 4b and Fig. 3b are
similar except for the image sizes. The nano-clusters in Figure 4.2b are not distinguishable in
Figure 4.3b.) Increasing the LPS fraction to 1:30 caused a marked increase in the number of the
macro-clusters (Figure 4.3d). Despite the striking difference in their numbers, macro-clusters in
both bilayers had a height of ~2 nm. Collectively, our AFM experiment on two LPS/POPC bilayers
with varying LPS fractions showed that the degree of lipid clustering induced by colistin is
positively correlated with the fraction of LPS in LPS/POPC bilayers.

Figure 4.5 Solution AFM images of an LPS/POPC 1:30 bilayer in 5 mM MgCl2 before (a) and
after (b) exposure to 5 µM colistin. Height scale is 5 nm. Scale bars are 200 nm.

Next, we examined the effect of the peptide concentration in mediating colistin-bilayer
interactions. We used an LPS/POPC 1:30 bilayer as the control system – AFM image of the control
bilayer is the same as Figure 4.3c. Exposure of the control bilayer to 5 µM colistin caused the
formation of many macro-clusters (Figure 4.4a). The number of macro-clusters increased
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significantly when the peptide concentration was increased to 10 µM (Figure 4.4b). Note that the
cluster height is similar at the two peptide concentrations. Altogether, our AFM measurements of
an LPS/POPC bilayer showed that the number of macro-clusters induced by colistin is proportional
to the peptide concentration.
Lastly, we investigated the effect of magnesium ions on colistin-induced bilayer
remodeling. The control bilayer of LPS/POPC 1:30 was prepared from SUVs in the presence of 5
mM MgCl2. AFM image showed that the control bilayer had a few small spots likely caused by
magnesium ions-induced LPS aggregation (Figure 4.5a). Exposing the control bilayer to 5 µM
colistin in conjugation with 5 mM MgCl2 did not result in marked changes in the bilayer structure,
although the number of small spots increased moderately (Figure 4.5b). Notice that the small spots
in the presence of 5 mM MgCl2 had a different morphology compared to the nano-clusters in Figure
4.2b. Moreover, no macro-clusters were observed in the presence of 5 mM MgCl2 (Figure 4.5b).
Overall, by comparing Figure 4.4a and Figure 4.5b (the same bilayer composition and peptide
concentration), we conclude that magnesium ions inhibited the effect of colistin in inducing lipid
clustering in LPS-containing bilayers.

Figure 4.6 E.coli before adding colistin ( a), after adding 1µM (b) and 5 µM colistin (c) for 30
minutes. Scale bar for (a), (b),and (c) is 1µm , 2µm ,4µm respectively.
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4.2.3 Morphological changes induced by colistin in E.coli
We studied the effect of colistin on gram-negative bacteria, E.coli incubated at two
concentration for the various time period. Figure 4.6 (a) shows the control bacteria with rod-shaped
mostly smooth but also some with a slightly rough surface. Referring to minimal inhibitory
concentration (MIC) for the susceptible strain of E.coli [166], we choose two concentration at near
MIC value (1 μM) and above MIC value (5 μM) to investigate the morphological changes
developed by the effect of colistin.

Figure 4.7 E.coli after adding 1µM colistin and incubated for 1hr (a) and for 4 hours (b). Scale
bar on the diagram is 1µM.

E.coli incubated with colistin for 30 minutes have slight morphological changes Figure 4.6
b and c are the images taken after incubation with 1 µM and 5 µM colistin respectively. The edges
seem to be corrugated, multiple cells develop cracked or wrinkled structure. However, the shape
and content of the bacteria remain intact for both concentrations.
When the incubation time is increased to 1 hour, 1uM colistin seems to produce a more
dramatic effect.(Figure 4.7a) The surface of cells seems to develop bumps and valley. The edges
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of the bacteria seem to have ‘chopped off’ regions indicating the deformity on the cells. Still, no
visible lysis is developed. Further incubation of bacteria to 4 hours with 1uM colistin shows small
structures lying around or near the cells (Figure 4.7b). This debris might be clusters of LPS as
obtained in the bilayer experiment. The number of flagella decreased significantly too.

Figure 4.8 Morphology of E.coli after incubated with 5µM colistin for 1hr (a), 2hrs (b), and 4hrs
(c). Scale bar for each image is 2µM.
Treatment of bacterial cells with 5 μM colistin for 1hour induced severe change in
morphology (Figure 4.8a). Lots of cellular debris can be seen around the cells. Some of the cells
contained segregation of mass, leaving an indentation in some part and raised bumps on the other
region. Other cells have unusual raised mass content, most likely outside of the cell envelope. This
might be the leakage of intracellular content accumulating at the cellular surface. Most of the cells
have a similar accumulation of mass on their boundary when the incubation of colistin with same
concentration was carried out for 2 hours (Figure 4.8b). These structures are obtained
predominantly at the apex region for most of the cells. However, no regular pattern of evolving
bumps is noticed. Further treating the bacteria for 4 hours with 5 μM (Figure 4.8c) colistin showed
that the cells are flattened out with noticeable grainy surface. This might be due to losing the
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cellular content after leakage, leaving behind the hollow enclosure. Some of the cells still have
raised bumps at the apex region

4.3

Discussion
In this study, we used fluorescence spectroscopy and solution AFM to interrogate the effect

of colistin on membrane permeability and nanoscale structures. We are particularly interested in
the relationship between the content of the OM-specific LPS and the degree of membrane
restructuring induced by colistin. Our vesicle leakage experiment showed that colistin binding
impaired the permeability barrier of LPS-containing lipid vesicles. The maximum leakage % was
found to increase with the fraction of LPS. Addition of the divalent cationic magnesium ions
inhibited the effect of LPS in enhancing bilayer permeabilization caused by colistin. We used
solution AFM to determine the impact of colistin on nanoscale structures of LPS-containing lipid
bilayers. The AFM experiment revealed that colistin caused a marked change in bilayer
topography as evidenced by the formation of nano- and macro-clusters. We found that the degree
of lipid clustering was dependent on the LPS fraction; more extensive lipid clustering was
observed in lipid bilayers containing a larger fraction of LPS. In addition, more clusters were
formed at higher peptide concentrations. Lastly, magnesium ions were found to antagonize lipid
clustering induced by colistin.
We used a mixture of LPS and phospholipids to prepare vesicular and planar lipid bilayers.
Our choice of the lipid composition was based on several considerations. Firstly, it has been shown
that LPS/phospholipid bilayers are suitable for evaluating antimicrobial peptide-LPS interactions
[167]. Secondly, there is no experimental evidence to definitively prove that the outer monolayer
of the OM is exclusively composed of LPS [136, 168]. Interestingly, deep rough LPS was reported
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to coexist with phospholipids in the outer monolayer of the OM in Gram-negative bacterial
mutants [169]. Thirdly, the antibacterial activity of polymyxins is correlated with the content (and
the chemical structure) of LPS. Complete loss of LPS was reported to serve as a mechanism for
developing polymyxin-resistance by A. baumannii [170]. Similarly, LPS in cell wash solution was
found to reduce the susceptibility of P. aeruginosa to colistin [171]. Collectively, studies of colistin
interacting with LPS/phospholipid bilayers are useful to reveal the mechanism of OM permeation
caused by polymyxins.
Owing to their opposite charge states, colistin and LPS can form stoichiometric complexes
[139, 172]. The strong binding affinities of polymyxins to LPS have been broadly demonstrated
by using fluorophore-tagged polymyxins [141, 142]. There are two driving forces directing the
recognition of polymyxins toward LPS. The initial binding is facilitated by long-range electrostatic
interactions between the negatively charged phosphates of LPS and the positively charged DAB
of polymyxins. After initial binding, hydrophobic interactions between the hydrophobic tails of
the lipid A motif of LPS and the hydrophobic domains of polymyxins can further increase the
peptides' binding affinity. Many efforts have been made to elucidate the complex structure of
polymyxins binding to LPS at a molecular level. A comprehensive summarization can be found in
the review work by Velkov and coworkers [173]. In essence, the polycationic heptapeptide ring of
polymyxins resides in the vicinity of the interface between the lipid A motif and the
oligosaccharide core, while the acyl tail of polymyxins penetrates into the hydrophobic core of
LPS. The proposed complex models are in line with the electrostatic and hydrophobic driving
forces in stabilizing the binding of polymyxins to LPS. Unlike polyanionic LPS, zwitterionic
phospholipids have a weak association with polymyxins [174-177].
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The distinctive binding affinities of colistin to LPS and POPC are likely responsible for the
nano- and macro-clusters observed in our AFM experiment. Our observation of lipid clustering
has some similarity to an earlier study, which used a monolayer formed by E. coli total extract (no
LPS) [178]. Although their AFM experiment was performed in air, the authors obtained circular
protrusions (height of ~1 nm) with a radius of 20 nm or 120 nm, depending on the concentration
of polymyxin B. Another study using fluorescence polarization also reported domain formation of
polymyxin B and phosphatidic acid in the presence of phosphatidylcholine [179]. To explain the
clusters observed in our AFM experiments, we propose a schematic model of colistin bound to an
LPS/POPC bilayer (Figure 4.9). The insertion of colistin causes lipid redistribution such that LPS
and colistin segregate away from POPC to form isolated clusters. The cluster and the POPC patch
have a height difference of ~2 nm because of the bulky macrocyclic ring of colistin (and the
ordered oligosaccharide core of LPS). The probability of cluster formation is larger at higher LPS
contents (and colistin concentrations). Therefore, the proposed model is in line with our
observation of lipid clustering as a function of the LPS fraction (and the peptide concentration).
Magnesium ions have a strong binding affinity to LPS [140]. Introduction of magnesium ions will
competitively inhibit the binding of colistin to LPS [180]. Consequently, magnesium ions will
reduce the development of LPS-colistin clusters (Figure 4.9).
Our vesicle leakage experiment showed that colistin increased the permeability of
LPS/POPC bilayers; the maximum leakage % increased with the LPS fraction. Membrane
perforation is a popular mechanism proposed for the bactericidal activity of polymyxins. LPS tends
to decrease bilayer permeability by having a tighter packing of acyl chains [181]. Permeability
enhancement of LPS-containing bilayers (including the OM) can be achieved by pore formation
or an alteration in lipid packing [145, 168, 182].
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Figure 4.9 A schematic diagram depicting the proposed mechanism of colistin-induced clustering
of LPS molecules in mica-supported planar bilayers. The insertion of colistin into the
LPS/POPC bilayer causes a lateral redistribution of the LPS molecules. LPS-enriched
clusters are formed by electrostatic interactions between colistin and LPS. The protrusion
of colistin macrocyclic ring (and LPS oligosaccharide core) could account for the 2-nm
height of the clusters observed in AFM imaging. Owing to the discontinuity between the
cluster and the rest of the bilayer, solutes will have a larger probability of permeating
through the cluster edge. The model also predicts that bilayer permeability is positively
correlated with the total length of the cluster perimeter.

Based on electrophysiological measurements, Seydel and coworkers proposed pore-like
lesions induced by polymyxins in asymmetric LPS bilayers [156, 157]. Our high-resolution AFM
imaging did not show transmembrane pores induced by colistin. Note that we have previously
observed <10 nm-sized pores using the same AFM setup [89]. Instead of transmembrane pores,
we argue that the hypothetical lesions could correspond to cluster edges proposed in our lipid
clustering model. Owing to the discontinuity (and the height mismatch) at the edge of LPS-colistin
clusters, solutes will have a larger probability of permeating through the cluster edge. The total
length of the cluster perimeter increases with the LPS fraction. Therefore, our lipid clustering
model can account for the leakage behavior as a function of the LPS fraction in LPS/POPC
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vesicles. Because magnesium ions inhibited cluster development (Fig. 6), the probability of solutes
permeating through cluster edges is significantly reduced. Therefore, our lipid clustering model
also supports the role of magnesium ions in abrogating colistin-induced bilayer permeabilization.

4.4

Conclusions
Here we report the effect of the cyclic lipopeptide colistin on membrane permeability and

nanoscale structures of LPS-containing lipid bilayers. Fluorescence spectroscopy-based vesicle
leakage experiment revealed that colistin binding impaired bilayer integrity, leading to an
enhancement of the bilayer permeability. The maximum increase in the bilayer permeability was
positively correlated with the LPS fraction in LPS/phospholipid bilayers. Addition of the divalent
cationic magnesium ions suppressed the effect of LPS in enhancing bilayer permeabilization. We
used solution AFM to gain a structural perspective of colistin-induced membrane remodeling. We
found that colistin caused the formation of nano- and macro-clusters that protruded from the
bilayer by ~2 nm. Moreover, cluster development was enhanced by increasing the fraction of LPS
or colistin concentration but abolished by magnesium ions. To explain our experimental data, we
propose a lipid clustering model where LPS and colistin form large-scale clusters that are
segregated from the POPC patch. The discontinuity (and the thickness mismatch) at the cluster
edge will create a passage that allows solutes to permeate through. The degree of bilayer
permeation is proportional to the total length of the cluster perimeter. Because more clusters are
formed at higher LPS contents, our lipid clustering model supports the vesicle leakage data.
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5. PORE FORMATION INDUCED BY AMPHIPATHIC HELIX H0 OF ENDOPHILIN
BAR DOMAIN ON PLANAR LIPID BILAYER
5.1

Introduction
The BAR domain-containing protein superfamilies’ are associated with various cellular

activities, several of which are guided by membrane curvature sensing and generation. BAR
domains consist of coiled-coil 3-alpha helixes’ monomers of roughly half cones whose outer
surface is enriched with hydrophilic residues and inner surface with hydrophobic ones[183]. The
hydrophobic interaction between the internal surfaces of the monomers, arranged in opposite
direction, results in a symmetric BAR dimer consisting of the core with bundled six helixes and
two arms [183]. During this coupling, the hydrophobic surfaces are buried in the dimer contact
area [183] but forming an inner surface enriched with positive charges [184, 185]. Based on the
crystal structures, the superfamily of BAR proteins are categorized as i) classical BAR ii) N-BAR
iii) I-BAR iv) F-BAR [186].
Endophilin, in addition to the BAR domain, consists of N-terminus helix H0, a variable
length middle region and a src homology domain 3 (SH3) region [187, 188]. While SH3 domain
binds with proline-rich dynamin[189] and synaptojanin [190] during the process of synaptic
vesicle endocytosis, the BAR domain is responsible for sensing [191] and generating membrane
curvature[186]. At lower BAR protein concentration, it works as a membrane sensing whereas at
higher concentration it can deform membrane and induce membrane curvature resulting tubulation
and vesiculation [186, 191]. N-BAR domains are suggested to bend membranes by two
mechanisms. The concave surface of the BAR region is suggested to form a scaffold on the
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membrane substrate, predominantly with negatively charged lipid bilayers [191, 192]. Upon
binding to a lipid membrane, the unstructured N-terminal region of N-BAR assembles to an
amphiphilic helix H0 [193, 194]. The other mechanism suggests that the bending formation occurs
by inserting this helix H0 in the plane of the membrane. The midpoint of this helix embedded
aligns to the phosphate level of lipid headgroup on the proximal bilayer leaflet [193, 195]. This is
known as the wedging mechanism. Both mechanisms are shown to be highly coordinated for
working of endophilin [196]. The helix H0 is suggested to be responsible for sensing membrane
curvature through hydrophobic insertion in the region-containing lipid packing defects [195].
Simulation work has shown that folding of helix H0, which is mediated by packing defects, is
favorable for positive curvature surfaces rather than flat or negative curvature surfaces [197].
However, the role of helix H0 in the generation of molecular surface curvature is yet debatable.
Deletion of helix H0 in endophilin followed the linear sorting with membrane curvature, indicating
membrane curvature sensing capability [198] and tubulation activity with amphiphysin [191].
Such amphipathic inserts are also found in other proteins like epsins [199], and G-proteins [200].
Most of the experiments, with either wild type or mutant BAR domains, are performed
with vesicles or tubules that have curvature surfaces [191-194]. Here, we visualize the
modification on the surface of planar supported bilayer containing different lipids, induced by
amphipathic helix H0 of the endophilin A1 using AFM. This N-terminal containing peptide has 124

residues

of

human

endophilin

A1

with

an

amino

acid

sequence

of

MSVAGLKKQFHKATQKVSEKVGGA. We use the AFM topographic images to observe the
modulation induced by endophilin helix H0 on the lipid bilayers.
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5.2

Results
We studied the effect by endophilin helix H0 on the supported bilayers with different

composition using fluid AFM.

Figure 5.1 Mica supported lipid bilayers incubated with helix H0 of endophilin. POPC (1) and
POPC/POPE (2) bilayers before endophilin helix H0 incubation (a) and after 0.2 µM (b)
0.5 µM (c) incubation. Scale bars for all the images are 2μm. Height profile of the lines
across the figures are shown below the images. The depth of the pores for all the images
are around 4 nm.
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5.2.1 Endophilin helix H0 in neutral bilayer
We prepared supported lipid bilayer containing POPC or POPC+30mol % POPE, now on
termed as POPC/POPE to investigate the effect by amphipathic helix H0 of endophilin N-BAR
domain. Figure 5.1 (1a) shows the smooth POPC, and Figure 5.1(2a) shows POPC/POPE bilayers
before adding the endophilin helix H0 in them.
The bilayers were treated with either 0.2 or 0.5 µM endophilin helix H0 solution in
ultrapure water. Within less than 10-minute incubation with the peptide, the POPC bilayer was
perturbed by generating pores of different sizes. This indicates that the helix H0 is able to interact
with bilayer relatively quick. The height profile of the pores formed on the bilayer is ~4μm. This
indicates that the defects are across the bilayer, forming transmembrane pores. Nearly spherical
pores with slight variation in size are formed in the bilayer. With the increased concentration of
endophilin helix H0 (0.5 μM), and equal incubation time (around 10-minutes), the number as well
as the size of pores generated on the bilayer increased. At this concentration, the size of the pores
formed can be categorized into three distinct classes: small, medium and large size. This multiple
sized pore formation might be the disruption at a different stage or caused by distinctive subunit
complexes. At higher concentration endophilin (at 2µM), the bilayer was completely washed
away.
Intrestingly, the number of pores formed in POPC/POPE bilayers as shown in Figure 5.1
(2) are lesser than the ones obtained in POPC alone bilayer. The depth of the pore is similar to the
ones obtained in POPC bilayer incubated with the helix H0. However, for alike concentrations,
the size of the pore in POPC/POPE bilayer was larger than observed in POPC lipid bilayer.
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5.2.2 Endophilin BAR helix H0 in negatively charged bilayer

Figure 5.2 POPC/POPG bilayer treated with different concentration of endophilin helix H0.
Bilayer before helix H0 treatment (a) After 0.2 µM (b) and after 0.5 µM (c). Endophilin
helix H0 treated images were acquired in less than 10 minutes of exposure time. All the
scale bars are 2μm size

To investigate the effect of endophilin helix H0 in the planar bilayer containing anionic
lipid, we prepared bilayer of POPC/20 mol % POPG (POPC/POPG). We treated the bilayer with
endophilin helix H0 at a concentration of 0.2 µM and 0.5 µM. The disruption induced by lower
concentration endophilin helix H0 is similar to the damage induced in POPC bilayer at the
equivalent concentration. However, the disruption caused by 0.5 µM helix H0 is in a lesser extent
than the disruption caused in a zwitterionic lipid bilayer at the same concentration.
5.2.3 Endophilin BAR helix H0 with POPC/ cholesterol bilayer
We studied the effect of endophilin helix H0 in the bilayer containing cholesterol. This is
important because sterols like cholesterol are the major component of the plasma membrane and
modulator for membrane fluidity. Tinier transmembrane pores were formed in the bilayer
containing POPC+30mol% cholesterol incubated with 0.2 µM helix H0 for ~10 minutes (Figure
5.3(b)). The size of the pore is relatively smaller and does not increase with an increase in the helix
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H0 concentration (Figure 5.3(b)). Nevertheless, the number of pores formed in the bilayers are
somewhat similar to the pores formed in POPC bilayer.

Figure 5.3 POPC/Chol. bilayer treated with endophilin helix. Bilayer before treating with H0 (a)
and after treating the bilayer with 0.2 µM (b), and 0.5 µM (c) concentration. All the scale
bars are 2μm size

5.2.4 Time course effect on POPC/Cholesterol
The images obtained after incubating POPC/Chol bilayer with 0.2 µM endophilin A1 helix
H0 at different time-period shows the changes seen in the bilayer perturbation as in Figure 5.4.
The nature of pore formation remains almost the same over the image acquisition time frame.
However, the number of pores formed remains constant after at least 20 minutes of incubation
with endophilin helix H0. Variation in size of the pores is still observed even in longer incubation
time. We did not notice any healing of bilayer perturbation within almost an hour’s observation.
A similar experiment performed earlier with endophilin N-BAR suggested the healing of sliver
formation in an anionic bilayer [201]. This might suggest that the amphiphilic helix is not able to
heal the bilayer, but a complete N-BAR domain might be able to do so.
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Figure 5.4 Time dependent effect of helix 0 on POPC/Chol bilayer. Images are taken as the bilayer
was exposed to 0.2µM endophilin helix H0 for.10 minutes (a) 21 minutes (b), 33 minutes
(c), and 47 minutes(d).The number and size of the pore formation were saturated after 33
minutes incubation period.

For most of the lipid bilayers incubated with endophilin helix H0, around the center of the
pores, small bright spherical structures were observed. Interestingly, the washed away POPC
bilayer surface by 2 µM endophilin concentration contained mesh-like features built of similar
spherical structures. The height of these structures is comparable with the height of the bilayer.
These spherical structures might be the adhered remnant helix H0-bilayer cluster or H0 oligomers.
The bright spots might be due to loosely attached bilayer clusters, which are attracted to the
cantilever tip and pulled away during scanning.

5.3

Discussion
Here, we study the interaction of the N-terminal amphipathic helix H0 of the endophilin1

BAR domain on planar lipid bilayer using AFM in the fluid phase. We observed transmembrane
pores generated in all the lipid species bilayer that we used for our experiment. This is the first
kind of studies on planar lipid bilayer with endophilin N-terminal helix H0 alone for membrane
modification.
Our selection for the concentration of the endophilin helix H0 is near to and higher than
the concentration of endophilin found in the proximity of the site during the generation of synaptic
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vesicles(~1µM)[193]. However, the concentration we use does not necessarily refer to the quantity
that is bound to the surface of the bilayer. Nature of insertion of the amphiphilic helix in the
monolayer exposed to it is in question. This insertion, not transmembrane, generates an expansion
which is resisted by the other monolayer. Hence, to minimize this stress, the membrane must bulge
or protrude towards top monolayer[202]. In addition, the interaction between helix H0 regions of
different N-BAR endophilin during deep insertion has been reported in an earlier study [203]. The
lower concentration of endophilin in the bilayer is found to be a promoter of the membrane
curvature sensing while the higher concentration promotes vesicle formation or tubules generation
[204]. We believe similar protrusion or cellular structures are generated with helix H0 after
insertion into the membrane. However, in the flat bilayer, while scanning with AFM tip, such
formed structures or protrusion might be disrupted and dragged away during the imaging process
leaving behind the transmembrane pores. Additionally, the size of the pores formed on the bilayers
is much larger than the typical size of the vesicles/neck of tubules formed by endophilin N-BAR.
We attribute this to the extensive pairing of H0 helixes’ binding to a site of probable packing
defects. A similar AFM study on lipid bilayer was performed earlier with endophilin NBAR
domain showing the sliver formation at higher concentration [201].
Another noticeable feature of the disruption mechanism is the edges of the defect. The
edges are not smooth but consist of very uneven horizontal protrusions. This implies that the
extraction of lipids from the bilayer by helixes is carried non-uniformly.
Contrary to the formation of slivers with the NBAR domain only on anionic lipidcontaining bilayer, this helix H0 generated transmembrane defects on the bilayers containing both
negatively charged lipid and purely neutral lipid. A possibility of binding of the helix H0 to the
neutral bilayer, though weakly, has been suggested [194]. We believe that this binding is due to
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hydrophobic interaction with the lipid bilayer and not electrostatic one. The binding is strong
enough for the insertion on the outer monolayer. Eventually, this incorporation of helix H0 in the
bilayer is able to generate morphological structures or bulges which when scanned with AFM are
disrupted by the tip, and observed as defects in the bilayer.

Figure 5.5 POPC/POPE bilayer exposed to 0.5uM helix H0 concentration (a) and POPC bilayer
with 2μM helix H0 concentration (b). Scale bars are at 0.2 μm and 2μm respectively.
Height profile of dotted line across the image (a) is shown below the image.

Furthermore, since cholesterol is one of the important components of membrane bilayer
influencing the fluidity and thickness, we studied the effect of helix H0 in the supported bilayer
containing cholesterol. The influences on the peptides in presence of cholesterol have been shown
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in a number of studies. In our studies, the size of the pores generated on the cholesterol-containing
bilayer were smaller than the bilayer without it. This might suggest that the helix H0 is prone to
attach with more fluidic bilayer and generate larger transmembrane defects.

5.4

Conclusion
In this study, we investigated the effect of amphiphilic helix H0 of endophilin BAR domain

on the planar lipid bilayer. This amphiphilic helix is suggested to insert in the bilayer during the
remodeling of the cell membrane. Endophilin helix H0 is found to bind with the planar bilayer
without showing the lipid specificity. Transmembrane defects are observed on the bilayer instantly
when scanning with the AFM. The number and size of the defects saturated below 30 minutes of
incubation time with the cholesterol-containing bilayer. Our experiment with amphiphilic helix
H0 of endophilin suggests the interaction with the planar bilayer is independent of lipid type.
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6. CONCLUSIONS AND FUTURE DIRECTIONS
6.1

Conclusion
The purpose of this work is to study the interaction of bio-medically relevant

macromolecules with the model lipid bilayers. We studied the peptidomimetics E107-3 and
colistin as a compound related to treatment for drug-resistant species. Along with, we also studied
the effect of N-terminal amphipathic helix H0 of endophilin on the solid supported lipid bilayer
membrane. A number of techniques like vesicle permeability, aspiration of the GUV, and mostly
fluid AFM were used during studies. We found out that the potential antimicrobial
peptidomimetics E107 is able to permeate through the membrane inducing nanoscopic
heterogeneous structures. We also found that the puncture force and membrane compressibility
modulus decreases with increasing E107 concentration incubated on the bilayer. Membrane
permeability of the LPS containing vesicles is enhanced with increased colistin concentration.
Increment in membrane permeability is also positively correlated with increased fraction of LPS
content on vesicles. However, the addition of magnesium ions diminishes the effect of increased
permeability with LPS containing vesicles. Along with raised membrane permeability, colistin is
able to form nanoscopic and macroscopic clusters protruded ~2nm on the surface of LPS
containing bilayer. We observe the generation of transmembrane defects by the amphiphilic helix
H0 of an endophilin BAR domain on both anionic and purely zwitterionic lipid supported bilayer
as observed by the AFM.
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6.2

Future Studies
The rapid evolution of antimicrobial drug resistant species is demanding immediate

attention to seek effective treatment. Many drug resistant species are found to modulate their
membrane to hinder the effect of the antibacterial agents. In this scenario, the importance of the
study about the antibacterial agents with the bacterial membrane mimicking model is even
magnified. A further detailed study in this field with more diverse instruments and methodology
is required to get a better understanding. This includes the study of real bacterial cells, both
susceptible and resistant, with the antimicrobial agents. A more detailed study on change in
mechanical properties of the outer membrane by antimicrobial agents of such species is essential.
And in-depth understanding of surface modification of bacterial cells by antimicrobial agents helps
to design and develop effective treatment agents or methods.
Moreover, the studies with N-BAR endophilin amphiphilic helix H0 is limited to only flat
supported bilayer with certain lipid species. Further study of this helix H0 with other curvature
bilayers like GUVs is essential. More robust methodologies needs to be used to decipher the
binding mechanism of endophilin helix H0 on membranes. Additionally, the study in the planar
bilayer with wild type and other mutants of the BAR domain will definitely provide a better
understanding of the curvature generation and sensing mechanism.
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